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ABSTRACT
Facilitatory and depolarizing drugs both produce

facili~tion

of the

cat skeletal muscle, and antidromic firing in the motor nerve following an
orthodromic stimulus.
Drugs were administered i. v. or close-ar-::e:c1ally to the anterior
tibialis muscle of the cat, and gross motor nerve potentials were
recorded from the ventral root.

Antidromic firing following an

orthodromic stimulus was asynchronous in the presence of facilitatory
drugs and a mixture of synchronous and asynchronous firing in the
presence of depolarizing drugs.

The dep.:>larizing drugs and neostigmine,

edrophonium and ambenonium also produced antidromic firing in the
. absence of nerve stimulation.

Methoxyamb(monium augments the

antidromic firing of the depolarizing drugs following an orthodromic
stimulus butprevented that in the absence of nerve stimulation.
Hemicholinium and triethylcholine prevent the antidromic firing produced
by both facilitatory and depolarizing drugs.

Tubocurarine also prevented

the antidromic firing by both types of drugs.
The results are explained on the basis of two cholinoceptive sites
on the motor nerve terminal, one at the first node and one on the
unmyelinated terminal.

3

ACI<:NOWLEDGEMENTS
/
I wish to express my gratitude to Dr. L. C. Blaber for his guidance,

encouragement and understanding throughout this research.

I would also like to thank Dr. A. G. Karc zmar for knowledge
imparted to me throughout my stay at Loyola.

4

CONTENTS
INTRODUCTION
I.

I I.

Anatomy
Physiology
A.

Membrane theory

B.

Neurophysiology

C.

Acetylcholine
a. Synthesis
b. Storage
c. Release
d. Cholinesterase

TII.

Pharmacology
A.

Neuromuscular compounds
a. Neostigmine
b. Edrophonium
C:

Oxamides

d. Depolarizers
e. D-tubocurarine
B.

Nerve terminal as a site of action

/

5

MATERIALSAND METHODS

/

I. In Vivo Experiments

II.

A.

Preparation for. the administration of drugs

B.

Recording of m£Chanical response

C.

Recording of muscle potential

D.

Preparation of spinal cord

E.

Recording of nerve potential

F.

Experimental procedure

In Vitro Experiments (Microelectrode)

RESJLTS

I.

Effects of S.ngle Drugs
A.

The effect of facilitatory and depolarizing drugs following
stimulation by a single volley

B.

The effect of facilitatory and depolarizing drugs in the absence
of nerve stimulation.

II.

III.

Interaction at the Nerve Terminal
A.

Combinations of test compounds

B.

Effect of transmitter depletors

C.

Tubocurarine

Micr·.:.~electrode

S::udies

,.......-.

6

DI5CUSS:ON
/

I.

Effects of S.ngle Drugs
A.

The effects of facilitatory and depolarizing drugs following
stimulation by a single volley

B.

The effect of facilitatory and depolarizing drugs in the absence
of nerve stimulation

II.

Effect of Drug Combinations
A.

Effect of the combined administration of any two of the
facilitatory and depolarizing drugs following stimulation by a
single volley

B.

The effect of a combination of any two facilitatory and
depolarizing drugs in the absence of nerve stimulation

C.

The effect of tubocurarine on the response of the facilitatory
and depolarizing drugs in the motor nerve

D.

The effect of facilitatory and depolarizing drugs when
acetylcholine is depleted from the nerve terminal

m.

The Effect of Depolarizing Drugs on Miniature End-plate
Potential Frequency

IV.

General Di.scus sion

BffiLIOGRAPHY

/

INTRODUCTION
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There is now some agreement that facilitatory drugs have an action
at the motor nerve terminal in mammalian muscle (for refe/ences see
Werner and Kuperman, 1963; Karczmar, 1967).

However, the sites and

mechanism of action have yet to be elucidated.
Masland and Wigton (1940) concluded that neostigmine inhibited
cholinesterase and allowed acetylcholine to depolarize the motor nerve
terminal.

This mechanism of action was restated by Eccles ( 1964).

Riker

and his co-workers ( 1957, 1959) and Blaber and Bowman (1963 a &b)
concluded that various hydroxyaniliniums (including neostigmine) and
oxamides had a direct action on the terminal producing facilitation which
was not mediated by acetylcholine.

Furthermore, Hubbard, S:hmidt and

Yokota (1965) have concluded that neostigmine has two actions at the
terminal, one to depolarize the first node and the other to produce
antidromic firing in response to an orthodromic stimulus.
The object of the present experiments was to determine whether
facilitatory drugs produce their action by a direct depolarizing action
at the motor nerve terminal, by a depolarizing action mediated by
acetylcholine or by some other action.

To achieve this, facilitating drugs

have been compared with depolarizing drugs in their
nerve terminal.

a~tions

on the motor

9
A short account of the anatomy and physiology of the neuromuscular
/

june tion precedes a more complete review of the present state of the
problem.

_. ..
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I.

ANATOMY
The study of the structure of the neuromuscular juncti<in. is of

considerable interest, for only in the last decade has it been possible,
with the use of the electron microscope, to find new elements of structure
which begin to provide a morphologic basis for the understanding of the
transmission process (Figure 1}.
The terminal motor axon loses its myelin sheath close to its
-branching, the branches making a series of contacts with the motor endplate.

Each fiber ends in a synaptic gutter (a depression in the muscle

surface that accommodates the axon terminal (Robertson, 1956).

The

terminal is surrounded ·by thin projections of S::hwann cell cytoplasm that
extends over the synaptic cleft (''primary cleft!').

The axon terminal and

muscle fibers are separated by continuous membranes (Couteaux, 1960}
and the muscle plasma membrane is thrown into a series of deep
infoldings {"secondary clefts"), some of which are branched or
anastomose with the neighboring infoldings.

These "junctional folds"

(C outeaux, 1944), {"subneural apparatus", C outeaux, 194 7} run at right
angles and parallel to the fiber axis and communicate with the ·.external
space at both sides of the nerve terminal which they surround.
A moderately dense homogeneous material occurs in both the
primary and secondary synaptic clefts (Barrnett, 1962; De Robertis, 1964}.

..

-.s.rn~.....-.~----~·•.:v-.-~tto...:....z~~_..~..~~:;:n..~.~~~w~~~'"·""""'•
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FIGURE 1
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The pre- and postsynaptic membranes show specialization consisting of
patches of high electron density called "active points" (Coutefux, 1961).
The axolemma follows at a 1000 A 0 interval the general outline
of the junctional trough without penetrating the subneural infoldings.
Two organelles characterize the axoplasm: mitochrondria and vesicles.
The terminal axonal branches have a much denser mitochondrial content
than the axon (Eccles, 1964).
In the motor· nerve terminals the vesicles are grouped in clusters
near, or directly upon that part of the presynaptic terminal that fronts the
synaptic cleft (Birks, Huxley and Katz, 1960).

The vesicles are postulated

to flow toward the axonic terminal mem".Jrane:·and discharge the chemical
mediator into the intermembranal cleft.
~naptic vesicles are hollow spherical elements of about 500 A 0

in diameter, and by chemical methods it can be shown that the transmitter
acetylcholine is concentrated in the subfraction containing the synaptic
vesicles (DeRobertis, Pellegrino de Iraldi, Rodrigues de Lores Arnaiz,
and fulganicoff, 1962; DeRobertis, Rodrigues deLores Arnaiz,
fulganic off, Pellegrino de Iraldi, and Zieber, 1963}.

De Robertis et. al.

(1963} has shown the presence of choline acetylase in the synaptic vesicles;
however, the:!."•;! i.o:1 some controversy about this.

Fonnu.m {1966) claims

tne lnembra:n.t:-botmd cholin·::: acetylase is an artefact due to the low iomc
strength and low pH of dilute water suspensions of synaptosomes used by

13

the De Robertis group.

The unifonn size of the vesicles corresponds with

the uniformity that is indicated for the packets of transmittey responsiqle
for the miniature end-plate potentials (m. e. p. p. 's), and for the failure
to modify the size of these packets by experimental means (Del Castillo and
Katz, 1956) .. The packets have the same size for muscle of very different
diameters.

Due to different input resistances them. e. p. p. 's are more than

ten times larger in the smaller fibers than in the larger (Katz and Thesleff,
1957).

The quantalliberations occur at a multitude of foci distributed over

the whole area of the synaptic contact (Del Castillo and Katz, 1956) which
also corresponds with the distribution of vesicles.
Recently, Birks (I 966) revealed more in regard to the vesicular structures contained in the nerve terminal.

After fixation of frog axon in

acrolein, Birks saw large diameter tubules that were long and winding,
sometimes branched, and that tended to lie with their long axes at right
angles to the long axis of the nerve with one end often in contact with the
axolemma in the region where it made synaptic contact with the sarcolemma.
Occasionally, the lumina of the tubules appeared to open into the synaptic
space, that is, the space between axolemma and sarcolemma.
Birks was able to show uptake of thorium dioxide particles by
synaptic vesicles and both small and large diameter tubules.

These

particles penetrated the axon-Schwann space when the concentration was
high, but penetrated the synaptic space at both high and low concentrations.

1111""'"'
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Because of the location of large and small diameter tubules in the nerve
/

endings Birk::: 3uggested that the large diameter tubules and vesicles
take up the particles from the synaptic space and the small tubules take
up the particles from the axon-S:hwann space.

Birks proposed that the

vesicles open momentarily through the axolemma, discharge their
acetylcholine and pick up

py

pinocytosis, or a combination of pinocytosis

and specific binding, ,the choline fragment;after hydrolysis of the
liberated ester for resynthesis into acetylcholine in the nerve endings.
The possibility of storage of acetylcholine in the synaptic tubules is also
an attractive concept from Birks' work.

These tubules have been observed

elsewhere; Barr-:1ett ( 1962), using rat diaphragm occasionally noticed
elongated profiles of membrane-bounded tubules having the same
diameter as the ~esicles (200-400 A 0 ) occurring adjacent to the populations
of vesicles.

Several functional problems can be formulated with regard to

the vesicles, though, as yet, none are satisfactorily answered: the mode
of production of the vesicles; the control of their movement up to the
synaptic cleft; and their sul:aequent fate after extrusion of contents.

15

PHYS:OLOGY
-------

II.

A.

/

Membrane theorr

It has been known for nearly a century that small electric currents
propagate nerve impulses along axons.

All modern concepts as to the

mechanism of conduction are still based on the so-called membrane theory.
According to this theory, the nerve fiber is surrounded by a semipermeable membrane which has a positive charge on the outside and a
negative one on the inside.
permeability at the

ac~ve

When a stimulus reaches a membrane, the
site is greatly increased for all ions with a

concomitant decrease in resistance.
thereby, small electric currents are

The active part becomes depolarized;
gener~ted

which stimulate the

adjacent poit_1ts, and the same process takes place there.

In this way,

-

successive parts of the membrane are activated and the impulse is
propagated along the axon.
in the last century.

Only one modification has become necessary

At the activated point there is not just a simple

neutralization but a reversal of polarity; the inside becomes p:.>sitive and
the outside negative (Curtis and Cole, 1942).

During the pas sage of the

impulse the charge does not just disappear, as was assumed originally,
but is reversed.
In o:t!de1· t"'

e·~nL=d.n

the reversal of membrane potential during the

impulse it is assumed that at the crest of the spike the membrane is

16
selectively permeable to the sodium ion.

The assumption is supported
/

by the observation that the action potential of many excitable tissues
fails in the absence of external sodium.
by the flow of

c•~rrent

Propagation is brought about

between resting and active nerve.

The current

reduces the membrane potential just ahead of the active region by
drawing charge out of the membrane capacity.

As a result of the decrease

in membrane potential the permeability to sodium rises and sodium ions ent
making the inside of the fiber electrically positive.

In this way a wave of

internal positivity and of increased sodium per:meability spreads along the
nerve fiber.

The propagating agent is the electric current which is

generated by the change in permeability.

The rise in sodium permeability

is short-lived, and potassium permeability increases during the latter
part of the action potential.

The effect of these changes is that after a

short period (0. 3 msec.) potassium ions leave the fiber faster than sodium
ions enter.

The outward migration of potassium ions restores the

original potential difference across the membrane capacity, and after a
brief period the fiber is once more in a condition in which it can again
conduct an impulse.

The motor nerve to the anterior tibialis muscle consists of fibers
1-20 microns in diameter.

An impulse travels in this type of fiber at a

speed of 5-120 metP.rs per second with a spike duration, including the
absolute and relative refractory periods in the order of 0. 4-0. 5 milli/
seconds. The negative after potential ranges from 12-20 milliseconds and
represents 3-So/o of the spike height.

The positive after potential is 40-60

milliseconds in duration and represents approximately 0. 2o/o of the spike
height (Gasser, 1941).

The nerve divides approximately seven times and

innervates in the order of 120 muscle fibers comprising a motor unit
(Sherrington, 1925; Clark, 1931).
throughout the entire muscle.

The units are not com pact but are spread

In most mammalian muscles there is a one

to one ratio between nerve branches and muscle fibers; that is, each
muscle fiber is innervated by· only one nerve branch.

The tibialis anterior

muscle of the cat has been used for the experiments disc us sed in this
thesis and consists of such focally innervated muscle fibers.

At the

terminal the axon loses its myelinated sheath {Wagner, 184 7).

Hubbard

and Schmidt {1961) have shown that in the motor nerve terminal the time
course of the action potential is 1. 3-3 milliseconds, the negative after
potential is 15-30 milliseconds, and the positive after potential is 50
milliseconds, although these may prove to be the properties of the action
potential at the first node {see Hubbard, Schmidt and Yokota,
closely resemble the properties of the main axon.

196 5) and

The theory that the

nerve terminal is passively depolarized by electrotonic spread
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(Eccles, 1964) has been disproved (Katz and Miledi, 1965 a, b), and
acetylcholine release from the terminal is related to active pfopagation.
As recorded ex:tracellularly, values of synaptic delay for the
neuromuscular junctions of mammals and amphibia respectively are in the
order of 0. 5 and 0. 6 msec. (Eccles, Katz and Kuffler, 1941). ·Recently,
Katz and Miledi (19S5 a & b) have applied the method of recording "focal"
potential changes in the frog nerve sartorius preparation to the measurement of synaptic delay.

At 20°C the synaptic delay had a minimal

duration of 0.4-0. 5 msec. and a modal value of 0. 75 msec.

Hubbard and

S:hmidt (1963) have reported a value of 0. 22 msec. for a single neuromuscular synapse of the isolated rat diaphr.agm which makes it the
briefest yet :l:"eported.
£:.__;'\_s~lc holine

It is now generally accepted that acetylcholine is responsible for
the transmission of the excitation from the nerve endings to the motor
end-plate.

The classical work of Brown, Dale, Feldberg, and many

others clearly established by the late 1930's the role acetylcholine pJ.aye:l
in transmission at the skeletal neur.l':)muscular junction by demonstrating
a substance identifiable as acetylcholine in the perfusion fluid after
indirect stimulation of the hind limb muscles of the cat.

Injection of this

substance into arteries supplying the gastrocnemius muscle caused a quick

~·--_...,;,...-------------------------,
~
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contraction of the muscle (Brown, Dale and Feldberg, 1936), though none
was demonstrated during activity of denervated muscle
and Vogt, 1936).

(Dal~,

Feldberg

fubsequent work has confirmed that stimulation of

motor nerves in isolated muscle preparations causes the release of
acetylcholine (S;raughan, 1960).
It appears that skeletal muscle contains small amounts of acetylcholine

and that, in the denervated muscle, some acetylcholine may be present in
the S:hwann cell remnants of the nerve (Birks, Katz, and Miledi, 1960};
thus, both resting and denervated musclcu release some acetylcholine
(S;raughan, 1960; Krnjevic' and Mitchell, 1961; Mitchell and S.lver, 1963).
Krnjevic' and S:raughan (1964} showed that the mean release of acetylcholine
in resting denervated rat diaphragm was 1/2 of that in normal muscle.
However, innervated stimulated muscle liberates some six times m·ore
acetylcholine than either resting innervated or active denervated muscle
(KrnjP.vic' and S;raughan, 1964). "Results of Hayes and Riker (1963) that
there was no difference of acetylcholine release upon stimulation of.· normal
and denervated rat diaphragm seem anomalous and the basic contention of
Dale and Feldberg (1934) and Dale, Feldberg and Vogt, (1936}, remains. in
full force today " (Karczmar, 1967}.
Tt should be mentwned that Nachm<-<-nsohn, on the basis of biochemical
studies, does not accept this classical theory of neurohumoral transmission

20
and claims that acetylcholine does not act between cells, but that it is the
essential trigger for the initiation of permeability changes which permit
/
ion movements across excitable membranes in general.
basically

s~milar

Its role is

for all membranes whether they are conducting or

snyaptic membranes.
a.

Synthesis of acetylcholine

Cholinergic fibers contain an enzyme, choline acetylase, which in tne
presence of adenosinetriphosphate forms acetylcholine by transferring
acetate from acetyl coenzyme A to choline (Nachmansohn and Machado,
1943).

Acetylcholine, choline acetylase, and cholinesterase (responsible.

for the destruction of the transmitter) are not confined to the nerve
terminals but are found in significant amounts along the whole length of the
nerve trunk.

A few days after severing a nerve axon, acetylcholine,

choline acetylase, and cholinesterase accumulate at the proximal stump
and disappear from the peripheral portion of the nerve (Hebb and Waites,
1956; Sawyer, 1946).

It has been suggested, therefore, that the

enzymes are synthesized in the nerve cell body and are carried to the
nerve endings by the axoplasmic current streaming down each fiber
(Macintosh, 1959; Koelle and Koelle, 1959).
Maclr-tosh has concluded that glucose (or lactate or pyruvate, which
could replace it) is essential for acetylcholine synthesis.

This is because

the formation of acetyl-GoA, and therefore of acetylcholine, might be

.,....-

------------------------------------------------------~
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inadequate to maintain the transmitter stores at their nor!l)B.1level in
the absence of an extracellular source of acetyl groups.

It is also clear

that the level of extracellular choline is an important limiting factor
for acetylcholine turnover during sustained activity at synapses (Birks
and Macintosh, 1961}.

Usually there is mo.,.e than enough choline in

the plasma to support synthesis, no matter how heavy the traffic of
nerve impulses.

Choline, being a quaternary compound, is unable

to penetrate nerve axons by passive diffusion; therefore, the nerve endings
must extract the choline from the extracellular fluid.

Birks and

Macintosh ( 1961} have postulated a choline carrier in the terminal
axonal membrane.

The rate of acetylcholine synthesis in activated·

nerve endings appears to depend also on the extracellular sodium concentration; and there is good reason to believe that the speeding up of
acetylcholine synthesis which accompanies activity is a consequence
of the net influx of sodium into the nerve endings that also accompanies
activity.

During heavy activity the rate of acetylcholine synthesis at

first lags behind the rate of acetylcholine release, catching up when
the intra terminal sodium has risen far enough.
How the intra·cellular sodium level controls acetylcholine synthesis
is as yet a matter for speculation.· Since there is no reason to suppose

~-------------------------------------~------------------------~

that sodium activates choline acetylase, one can presume that it is involved
/

in some process governing the availability of the enzyme's substrates,
choline and acetyl-CoA, at the sites of synthesis.
b.

S:orage

The rate of acetylcholine discharge during nerve stimulation is
matched by the rate of synthesis.

When an anticholinesterase is present,

the rate of synthesis is somewhat greater than the rate of discharge
(Birks and Macintosh, 1961)_.

There is also some synthesis when the

nerve is at rest which has been shown to be as :much as ZO% of the
maximum rate that is attained during activity (Birks and Macintosh, 1961).
Thus, it can be said that the arrival of impulses at the nerve ending,
besides triggering the release of acetylcholine, also stimulates its
synthesis.
The additional acetylcholine, which accumulates in a resting or an
active ganglion whose cholinesterase has been inactivated, is clearly
bound in a different way from the regular acetylcholine of the ganglion.
Birks and Macintosh have called this "surplus" acetylcholine.

This

surplus acetylcholine accumulates within some intracellular compartment,
in which, under ordinary circumstances, it would be destroyed by
cholinesterase.

Its formation shows that there is a continued synthesis

z]
and breakdown of acetylcholine in or near the nerve endings, even at rest.
/

In terms of the vesicle hypothesis, one could say that surplus acetylcholine
represents acetylcholine within the nerve endings but outside the vesicles.
Using HC -3 as an inhibitor of acetylcholine synthesis Birks and
Macintosh ( 1961) observed the maximum depletion of acetylcholine
resulting from prolonged stimulation amounted to about 85o/o of the
original store.

The remaining 15o/o, which could not be released by

nerve impulses, was designated as "stationary acetylcholine,
to the "depot acetylcholine" which could be released.

11

in contrast

Part of the

stationary acetylcholine was located in the intraganglionic stretches of the
cholinergic axons, since the acetylcholine of the preganglionic trunk was
not depleted by activity in the presence of HC-3.

The depot acetylcholine

appears to be made up of a smaller "readily releasable" fraction, and a
larger fraction which serves as a reservoir from which the first is
replenished.

Exactly how this is accomplished is not known but the idea

of mobilization, i.e., the transfer of synthesized transmitter quanta into
a form, or a site, in which they are more likely to be liberated by nerve
impulses, provides a convenient basis for interpreting a number of
phenomena associated with repetitive activity at cholinergic nerve endings.
c.

Release

Even in the absence of nerve impulses there is a spontaneous release

2'1
of acetylcholine from the nerve endings giving rise to minute voltage
fluctuations in the region of the motor end-plate (m. e. p. p. '(} (Fatt and
Katz, 1952).

On the arrival of a nerve impulse there is a simultaneous

release of a large number of quanta of acetylcholine.

This is caused by

a depolarization of the terminal causing an influx of calcium which alters
the properties of the vesicles or the axoplasm just inside the membrane
so that the vesicles spill their contents into the synaptic gap (Birks and
Mac Intosh, 1957).

Depletion of calcium reduces the output of acetylcholine

and the frequency of miniature discharge.

Magnesium ions have the

opposite effect; an increase in magnesium ion concentration decreases
acetylcholine output (Del Castillo and Engbaek, 1954; Hubbard, 1961).
These findings suggest that acetylcholine release is determined by
intraterminal ionized calcium and that the latter is derived from influx,
accelerated by depolarization and dependent on extracellular calcium, as
well as from the variable membrane store of bound calcium controlled by
membrane potential.

There has been postulated a calcium-independent

fraction based on the observation that m. e. p. p. 's continue indefinitely
in the absence of calcium in the bathing solution, and even in the presence
of a chelating agent and high magnesium (Hubbard, 1961).

However, in

contradiction to this, Elmqvist and Feldman {1965a) have shown the
disappearance of m. e. p. p. 's six hours after treatment with EDTA of the

rat nerve diaphragm preparation.

When calcium was applied electro/

phoretically to this preparation, focal post-synaptic potentials appeared
demonstrating release of acetylcholine.

Lack of calcium had no effect

upon propagation of the nerve impulse.

Changes in the action potential

of the nerve terminal may not always be related to changes in acetylcholine
release (Katz and Miledi, 1965c), indicating that calcium and nerve
terminals depolarization may constitute two independent controls of
acetylcholine release from the nerve terminals.
Q

Birks (1963) and Gage and Qu,6stel ( 1965) have suggested that sodium
may also be involved in acetylcholine release.
pump appears to facilitate transmission.

Blockade of the sodium

Birks (1963) suggested that an

increase in intraterminal sodium is responsible for this effect.

Elmqvist

and Feldman (1965b) alternately have explained the effect as being due to
a mobilization of calcium.

Nishi, S:>eda and Koketsu ( 1965) have revealed

that bivalent ions, including calcium, exert dual actions on membranes.
Besides binding the membrane and controlling and limiting its permeability,
they also act as charge carriers by penetrating the membrane.

This

second effect which is sodium-like may be involved in acetylcholine
release.

Takeuchi and Takeuc!li (1962} observed in their experiments with

low sodium and normal calcium levels a depression of transmitter release
caused by a reduction of nerve terminal action potential amplitude.

26
The work of Katz and his colleagues (Del Castillo and Katz,

1956)

showed that the acetylcholine released at the motor nerve -ending by the
/

nerve impulse produces an increase in the permeability of the postjunctional element to various ions, thus causing it to be depolarized; the
depolarization then triggers the spike in the post-junctional element and
junctional transmission is completed.

Microelectrode techniques have

shown the quantity of acetylcholine necessary to produce a response is1. 5 X l0- 15 g.m. (Krnjevic'and Miledi, 1958), which, because of the

narrow gap at the junction, is a concentration of approximately 1 X 10- 3 M~
The combination of acetylcholine with its receptors on the end-plate paten-:tial reaches a threshold level {about 1/4 the resting value in the cat (Boyd
and Martin, 1956) ) the membrane is short circuited and surrounding
areas of the muscle membrane, still in the resting state, discharge into
this current sink and a muscle action potential is initiated and propagates
away from the end -plate region (Eccles, Katz, Kuffler,

1941 b).

The

amount of acetylcholine released is in excess of what is needed to reach
threshold (Brown, 1937), and yet it disappears quickly allowing the
end-plate to repolarize before the end of the refractory period of the
muscle fiber.
It is widely accepted today that the amount of depolarization of the
nerve terminal determines how much acetylcholine is released.

E. p. p. 's

are produced by acetylcholine released from presynaptic terminals 9-nd the

27

fr.::quency of m. e. p. p.ts. {but not their quantal size) are greatly increased
by the application of depolarizing currents to the presynaptic {erminals
and are decreased by hyperpolarizing currents (Del Castillo and Katz,
1954; Liley, 1956).

Hyperpolarization of the terminal is known to increase

the amplitude of the presynaptic spike.

This also leads to an increased

end-plate potential which is generally used as an indicator of the amount of
acetylcholine released.

Presynaptic amplitude and e. p. p. does not always

obtain an exact relationship _especially after conditioning of neuromyal
transmission (Hubbard and S:::hmidt, 1963).

Del Castillo and Katz ( 1954)

have referred to a ''dielectric breakdown" of the membrane in the hyperpolarized state and noted random bursts of m. e. p. p.' s. in this situation.
Katz and Miledi (1965a) ru~gest that hyperpolarization of the terminal may
be regulated by inside-outside sodium concentration, and block of the
sodium pump by drugs may cause accumulation of sodium in the cell and
lowering of the potential with consequent prevention of postetanic
facilitation.
Katz ( 1962) summarizes all the results by saying that "the frequency
of the miniature potentials is controlled entirely by the conditions of the

.

presynaptic membrane, while their amplitude is controlled by the
properties of the post synaptic membrane."

28

D.

Cholinesterase

Cholinesterase is responsible in part for the rapid disap~arance of
acetylcholine but the end-plate potential is still short-lasting in the presence
of cholinesterase inhibitors (Eccles, Katz, and Kuffler, 1942).

Other

mechanisms for th~ rapid removal of acetylcholine such as rapid diffusion
to subthreshold concentration (Ogston, 1955) or resynthesis to a chemical
precursor (Abson and Bjarke, 1945) have been suggested.

The presence of

cholinesterase may be merely an emergency mechanism for the removal of
abnormally excessive amounts of acetylcholine.

However, the artificial

conditions of some animal experiments may be what cause it to appear
unnecessary (Blaber, 1962).
The existence of an enzyme responsible for the destruction of the
humoral transmitter was suspected by_Loewi (1921) early in his studies of
the "vagusstoff" and later demonstrated by Loewi and Navratil {1926).
Later studies showed that those portions of skeletal muscle which had a high
concentration of motor end-plates also contained the most acetylcholinesterase (Couteaux and Nachmansohn, 1940).

The classic investigation by

Marnay and Nachmansohn (1937) demonstrated that there was enough
acetylcholinesterase in the end-plate region of the frog to hydrolyse the
amount of acetylcholine calculated to be released from the nerve terminal
during the few milliseconds of the refractory period.
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Koelle and Friedenwald (1949) first showed histochemically the
e:x:istence of a high cholinesterase activity at the level of the thotor endplate.

Barrnett (1962), using rat diaphragr:n, has added new knowledge

concerning the localization of cholinesterase at the myoneural junction.
The structures that demonstrated enzyme activity were the muscle plasma
membrane covering the junctional folds, the material in the primary and
secondary clefts, the plasma membrane covering the axon terminal and
vesicles and granules within the terminal axon.
enzyme activity on both sides of the junction.

These findings put the

The entire plasma membrane

of the axon did not show activity; only irregular short lengths of the membran::
were coated with the final product.

These were interrupted by short seg- .

ments of unstained membrane or gaps in which no surface membrane could
be made out.
The synaptic vesicles showed variations in activity.

In some cases

this was expressed by staining of the membrane which surrounded the
vesicle, while in others only a part of the membrane was stained and in
still others the entire content of the vesicle showed activity.

Occasional

linear segments of membranous material or short profiles of tubules were
reactive.

In some specimens, however, much of the final product appeared

in morphological forms unrelated to any of the known structures found in
the terminal axoplasm.

These consisted of granules, rods, and arc seg-
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ments and were localized in the most peripheral parts of the axoplasm of the
nerve terminals.

It should be recognized that vesicular and gi'anular

patterns of deposition may be the result of many factors, including sectioning, incubation or subsequent preparation.
These results do not support the speculation of De Robertis and
Bennett (1955) that the vesicles are associated with transmitter substance,
for any mediator would be destroyed by the cholinesterase.

Barrnett's

conclusion is thathis results supportNachmansohn's {1959) view ofnerve
muscle transmission that acetylcholine acts in both the pre- and postsynaptic membranes to permit ion flux, as occurs in axonal conduction.

.,....
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III.

PHARMACOLOGY
Numerous compounds capable of facilitating neuromuscul(r trans-

mission have been synthesized.

Many of these have been shown to possess

anticholinesterase activity, and it was natural to ascribe the effects of
these compounds on skeletal muscle to inhibition of the enzyme at the
neuromuscular junction with the c0nsequent preservation of the transm1tter.
In recent years the lack of correlation between the ability of certain of
these compounds to facilitate neuromuscular transmission and to inhibit
cholinesterase in vitro has led to research which has shown that some of
these compounds cause at lease a part of their facilitating action via other
mechanisms {Randall, 1950; Wescoe and Riker, 1951; Riker, 1953;
Karczmar, 1957; Blaber, 1960; Riker,

1960; Blaber and Bowman, 1962;

Edwards and Ikeda, 1962; Blaber, 1963; Standaert, 1963; Goode, Blaber,
and Karczmar, 1965; Kato and Fujimori, 1965; Hubbard, Schmidt, and
Yokota, 1965). {Figures Z(A) and Z(B).
A review of the classical mode of action of the compounds involved in
the present study will precede a review of more recent research which
points to newer sites of action for these compounds at the neuromyal
junction.
A.

Neostigmine

Neostigmine is a synthetic anticholinesterase which was developed as

FIGURE 2(A)
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an outcome of the studies of the cholinesterase inhibiting properties of
physostigmine. Although there is little difference between~ in~
potencies of neostigmine and physostigmine to inhibit cholinesterase in
various species (Nachmansohn, Rotherberg and Feld, 1948), the anticurare and twitch potentiating action of the former drug is much more
rapidin onset than that of the latter (Riker and Wescoe, 1946).

The

rapidity of action of neostigmine compared to that of physostigmine can
·probably be ascribed simply to a more rapid rate of combination with the
receptors (Blaber, 1962).
In the rat diaphragm, neostigmine antagonizes not only the
neuromuscular paralysis by curare but also paralysis by depolarizing
blockers such as decamethonium (&cher, 1951).
depolarizing blockade does not hold
of the blockade is observed

tr~e

(~owman,

This antagonism of

in the cat because an increase

1962). Neostigmine is known

to have a direct action at the neuromuscular junction in addition to its
anticholinesterase action (Riker and Wescoe, 1946) but this has been
shown to be too weak to contribute to its action at the neuromuscular
junction (&nith, Cohen, Pelikan and Unna, 1952; Hobbiger, 1952; Blaber,
1962). Berman-Reisberg (1957) showed that neostigmine inhibited
choline-acetylase, but 8 X 10-3 M was necessary to cause 50o/o inhibition
which is strikingly different from the potency to inhibit acetylcholinesterase, 50o/o inhibition being produced by 2. 8 X ~o-7 M, i.e., at a
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concentration of approximately 40,000 times less.

The finding that drugs

of this type potentiate the action of applied acetylcholine is ~rely a
demonstration that, in sufficient concentration, they possess an anticholinesterase action.

The question of whether this is the sole, or even the

main mechanism of action of these compounds in the effective doses is not
answered.
B.

Edrophonium

The compound edrophonium is a particularly interesting substance
because it reveals some of the weaknesses in the experimental methods.

It

is a quaternary compound which inhibits cholinesterase reversibly by
combining with it only at the anionic site, and thus blocks attachment of the
substrate (Holmstedt, 1959).

The rapid onset and short duration of action

of edrophonium with respect to neostigmine has been noted by a number of
investigators (Cowen, 1938; MacFarlane, Pelikan and Unna, 1950; Riker,
19'53; Wilson, 1955).

The ability of this compound to reverse the neuro-

muscular blocking action of tubocurarine is well known also, but the
earliest experiments indicated that it was only a feeble anticholinesterase,
about one-hundredth as potent as neostigmine (Randall, 1950; Hobbiger,
1952).

fullth, Cohen, Pelikan and Unna (1952)

obtain~d

results which

showed no .positive correlation between the relative potencies of the
compound as an anticholinesterase and its ability as potentiator of
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acetylcholine on the frog rectus muscle.

The inhibition of cholinesterase

by edrophonium was reversed by the addition of substrate too/rapidly for the
time course to be measured with the manometric technique.

The ev1dence

outained neither directly confirmed uor negated the thesis that the
potentiation of acetylcholine and antagonism of tubocurarine produced by
this compound is the result of its ip.hibition of cholinesterase {Snith, Mead
and Unna, 1957).
Direc" depolarization of the end-plate memorane with edrophonium
can be achieved by application of concentrations that are 100 times that
shown to be effective in antagonizing curare {Nastuk and Alexander, 1954).

C.

Oxamides

Ambenonium Cu..1.0r1de (Mytelase; W !N 8077) and metnoxyambenonium
Cu.LOride (WI.l\1 8078) are members of a series of bisquaternary oxamides
synthesized in the Sterling-Winthrop laboratories and first reported by
Arnold, &>ria and Kirchner ( 1954).

Both are synergistic with neostigmine

i'!l mice and have been shown to be reversible inhibitors of acet:j:c!tolinesterase {Karczmar and Howard, 1955; Koelle, 1957; Blaber; 1960;. Goode,
Blaber and Karczmar, 1965).

In this regard it was found that ambenonium

is more than 100 times a3 active as methoxyambenonium.

Ambenonium

reversal occurs extremely slowly except in the presence of relatively high
concentrations of certain cations (Koelle, 1957).

Ambenonium potentiates
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the respo.nse to the indirect single shock stimulation of cat muscle and
antagonizes curare blockade.

/

Although a powerful anti-curare agent,

methoxyambenonium does not potentiate the maximal twitch tension
(Lands and Karczmar, 1955; Blaber, 1960).

In the frog, ambenonium

augmented and prolonged the end-plate potential and acetylcholine
depolarization (Karczmar, Kim and Koketsu, 1961); methoxyambenonium
. only augmented but did not prolong these phenomena.

While ambenonium

augments the excitatory and_ paralyzing action of acetylcholine, succinylcholine and decamethonium on the cat 1 s tibialis muscle, methoxyambenonium
diminishes these effects (Karczmar, 1957).

Since methoxyambenonium an-

tagonizes paralysis by curare and depolarizing agents as well, Karczmar
stressed that the current theories on the mode of action of the depolarizers
offe:red an inadequate explanation for the properties of methoxyambenonium.
Blaber (1960), finding that both compounds antagonized the paralysis of
curare and depolarizers, ar:dved at the conclusion that larger doses than
those required to antagonize curare are needed to restore transmission
from paralysis by decamethonium.

Blaber also found that at these higher

doses, oxamides produced a neuromuscular block resembling, in many
ways, that caused by curare.

Accordingly, he suggested that the

antagonism of depolarizers was due to the curaremimetic properties of the
oxamides.
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The complexity of the detailed mechanism of action of the oxamides is
apparent.

/
There is no correlation between the relative potency of these

agents to antagonize curare paralysis and their cholinesterase inhibitor
potency in vit::.£·

While the neuromuscular block by oxamides resembles

that by curare since it is antagonized by tetanic stimulation and depolarizing
agents, it is unlike that produced by curare in that it is not antagonized by
neostigmine or edrophonium (Blaber, 1960).
D.

Depolarizers_

In the search for synthetic agents capable of blocking neuromuscular
and autonomic ganglionic transmission, that is, for substances blocking
the nicotinic effects of acetylcholine, thousands of interesting compounds
have been made and scores of chemical series·explored.

One of the most

fruitful discoveries was that of the British investigators who introduced
the polymethylene bis-trimethyl-ammonium series, referred to by the
generic term

11

methonium compounds. 11 This class of drugs was developed

simultaneously and independently by Barlow and Ing ( 1948) and Paton and
Zaimis (1949).

Potency was greatest in the bis-trimethylammonium series,

and unusually high activity at the neuromuscular junction was found when
the chain contained ten carbon atoms (decamethonium; C 10).
of these compounds is not like that of tubocurarine.

The action

They act like

acetylcholine in producing contracture of the frog rectus (Paton and
Zaimis, 19•1:9) or the chick biventer (Gins borg and Warriner, 1960), they
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depolanze the end-plate or the eat's gracilis muscle (Burns and Paton,
/
1951} and desensitize the end-plate of the tenuissimus muscle of the cat to

acetylcholine applied electrophoretically (Axels son and Thesleff, 1958}.
The ability to cause contracture of the frog rectus depends upon chain
length and is not actually maximal in decamethonium (Klupp, K:ra upp,
Stormann, and Stumpf, 1953}.

If given close arterially into the anterior

tibialis muscle of the cat they produce two types of responses.

After a

latent period, a small dose _produces fasciculations, while a larger dose
causes an immediate muscle twitch followed by fasciculations (Paton and
Zaimis, 1949, 1951).

Decamethonium has been shown to inhibit cholines-

terases, 50o/o inhibition of human plasma and rabbit erythrocyte
cholinesterase being produced by 6. 0 X 10- 5 M and 4. 5 X 1Q-5 M
concentrations respectively (Paton and Zaimis, 1949).
Succinylcholine (Bovet, Bovet-Nitti, Gua ... ino, Longo and Marotta,
1949}, another depolarizer, has been found to be a substrate for butyrocholinesterase (Glick, 1941) and it also inhibited human red cell
acetylcholinesterase; 2. 5 X 10-3M produces 50o/o inhibition (Evans, et. al.,
1952). (Figure 3).
The block of neuromyal transmission due to these agents can be
antagonized by tubocurarine.

However, depolarizing agents synergize with

ant cholinesterases (Zaimis, 1951, 1959).

Anticholinesterases increase

,.....

...

40
FIGURE 3

. CIH3

/

' CH3

I

H 3 C -N -CH 2 -CH 2 -CHz -CHz -CHz -CHz -CHz -CH 2 -CH 2 -CH 2 -N -CH 3

I

t
CH 3

CH 3

DECAMETHONIUM

H 3 C-N-CH 2 -CH 2 -0-CO-CH 2 -CH 2 -CO-O-CHz-CHz-N-CH 3

I

I

CH3

CH 3
SUCCINYLCHOLINE

41

the initial potentiation of muscle twitch by succinylcholine or decamethonium
and then intensify and prolong their blockade.

/
One explanation of this

phenomenon could be the protection of acetylcholine released upon nerve
stimulation which then could synergize with and prolong decamethonium
depolarization.

It has also been pointed out by Nastuk and Alving {1959)

that anticholinesterases containing onium grouping such as neostigmine
and edrophonium are depolarizing agents in their own right and thus could
synergize with decamethonium and succinylcholine.

Karczmar has

shown that certain oxamide compounds not only antagonize curare and
depolarizing types of blockade but convert the depressant action of
depolarizers upon the twitch response into .a pure excitatory effect, which
he refers to ,as "reversal 11 {Karczmar,_ 1957; Karczmar, Kim, and Blaber,
1965; Blaber and Karczmar, 1967).

Oxamides, as well as hydroxyanili-

niums, increase the e. p. p. obtained when neu:romyal transmission is
blocked not only by d-tubocurarine, but also by succinylcholine and
decamethonium {Karczmar, Kim, and Koke~su, 1961; Karczmar, et. al.,
1965).

This may be related to the fact that blockade by depolarizers may

have a competitive, d-tubocurarine-like component of action {Zaimis,

1951,

1959; Thesleff, 1955). This component is particularly pronounced in the
frog.
Experiments using C 14 decamethonium show that fixation and distribution of decamethonium in the end-plate are different from those
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of curarine (Waser, 1965).

Not only the end-plate itself is occupied but

also a wide area around this, varying. with the time interval.

/

According to

earlier hypothesis, the site of action of cholinergic molecules such as
acetylcholine, muscarine, and decamethonium are the cholinergic
receptors in the postsynaptic membrane of the end-plate in the vicinity of
pores (Waser, 1961).
depolarization.

These pores are essential for ion transport during

Their 0bstruction leads to a curare -like neuromuscular

block, whereas persistent opening leads to paralysis by depolarization.
The well-known change between depolarizing paralysis and hyperpolarizing
block observed some time after injection of decamethonium might thus be
due to an accumulation of molecules around the pores,. followed by
obstruction of these to permeation of the postsynaptic membrane {Jenden,
Kamijo and Taylor, 1954}.
E.

D-tubocurarine

Eince early demonstration of the decurarizing effect of eserine by
Pal ( 1900) and Rothberger {190 1), the antagonism by neostigmine,
oxamides, edrophonium-like compounds and other reversible anticholinesterases of the depression by d-tubocurarine of neuromyal transmission
has been amply demonstrated in the frog (Rosenblueth, Lindsley and
Morison, 1936) and mammals (Snith, Cohen, Pelikan, and Unna, 1952).
This antagonism extends to both single twitch and tetanus response to

~

---------------------------------------------------------------,
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indirect stimulation, as shown by Briscoe ( 1936).

Its blocking action on
/

transmission is particularly pronounced during the tetanus; it is
cumulative and frequency dependent, although this latter effect is not as
pronounced as in the case of drugs inhibiting the synthesis of acetylcholine.
This is a reciprocal action, d-tubocurarine being capable of antagonizing
neuromyal depression by anticholinesterases (Briscoe, 1936).

It is an

important point; because it illustrates a basic difference between
neuromyal block by anticholinesterases and d-t:ubocurarine.
D -tubocurarine

i~

a non-depolarizing blocking agent of neuromuscular

transmission, competitively antagonizing acetylcholine at the neuromyal
junction.lwhich first converts the spike into .the e. p. p. and then reduces the
latter (Thesleff and Quastel, 1965).

As a competitive blocker, d-tubocurar-

-

ine is antagonized by agents which release acetylcholine such as TEA
(Koketsu,. 1958; 3:ovner, 1958), by depolarizers, and by anticholinesterases.
D-tubocurarine has been shown to oppose the increase in duration and
amplitude of the e. p. p. produced by anticholinesterases (Eccles, Katz
and Kuffler, 1942; Feng and Li, 1941) and hydroxyaniliniums (Karczmar,
Kim and Koketsu, 1961).
Takeuchi and Takeuchi (1960) measured the effect of d-tubocurarine
on the end-·plate current, which is directly proportional to the extent of
occupation, by acetylcholine of the cholinergic re<:eptor sites (Eccles,

X\
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1964).

It was found that antagonism of d-tubocurarine of neuromuscular
/

transmission extends to the end-plate current.

Eccles, Katz and Kuffler ( 194lp) showed that there is a diminution
of the e. p. p. by d-tubocurarine which is due to the prevention by it of
acetylcholine depolarization of the end-plate.

This action allows a larger

fraction of the acetylcholine to be free and therefore available for
enzymic destruction.
Waser (1959), using radioactive tubocurarine and decamethonium,
identified

receptorswh~ch

bound these substances in the end-plate region.

Denervation produced spreading of the sites which bound the depolarizers
but caused disappearance of those binding Gurare.
F.

Nerve Terminal As a S.te of Action

Recent research with the compounds involved in the present study has
shown that the nerve terminal is a site of action for them.

Although much

-

of the work has been carried out in the last ten yeare, drug induced responses
on the terminal were observed almost 30 years ago.
In 1940, Masland and Wigbn showed in cats that repetitive firing
in muscle fibers produced by neostigmine was accompanied by repetitive
antidromic activity in the nerve.

They interpreted their results to mean

that the action of neostigmine was not a direct one, but when cholinesterase
was inhibited, the released transmitter was allowed to act on the nerve
endings.

Feng and Li (1941) observed the same response using physostig-

-
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mine but concluded that the antidromic activity in the nerve was a
consequence of a direct action of the compound upon the motof terminal.
Lloyd demonstrated in the following year ( 1942) that action

currents

in the muscle could re-excite the nerve and lead to antidromic responses.
Therefore, he suggested that the nerve excitation demonstrated in the
presence of physostigmine was due to the induced repetitive firing of the
muscle.

Eccles, Katz and Kuffler ( 1942) reached the same conclusion as

Lloyd although they were of the opinion that a fraction of the repetitive
nerve activity preceded that in the muscle and could not, therefore, have
been induced by the muscle action currents.
Riker and coworkers (Riker, Roberts, S:andaert and Fujimori, 1957;,
Riker, Werner, Roberts and Kuperman, 1959 a & b) studied theeffects of
several phenyltrialkylammonium salts which also caused repetitive firing
on the nerve.

In experiments in which the root filaments and the muscle

units were carefully matched, it could often be seen that the repetitive
nerve spike actually preceded that of the repetitive muscle spikes.

fuch

results seemed to exclude the possibility of retrograde activation of the
nerve by the muscle action currents as suggested by Lloyd, 1942).

Riker,

et. al. ( 1957) also pointed to the lack of correlation be_tween anticholinesterase ac;tivity and ability to induce repetitive firing in the nerve among
their series of comp0unds, and in contrast to Masland and Wigton they
concludedthat the drugs acted directly on the nerve endings.

Brown and

~
--------------------------------------------------------------,
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Matthews (1960) confirmed the results of Lloyd (1942) and established the
/
fact that currents generated in active muscle could ephaptically re -excite

motor nerve endings and that the time course is such that the re -excited
nerve endings can again excite the muscle.

The work of Lloyd ( 1942) and

Brown and Matthews (1960) showed that almost the whole of the summed
muscle action currents were necessary to back-excite the nerve endings, and
that the back-response was abolished by using a submaximal orthodromic
nerve volley.
Blaber (1962), comparing the same facilitatory drugs as used in the
present work, found that their ability to potentiate the muscle contraction
produced by a close -arterial injection of ac.etylcholine was closely correlated with

their_!_~

vitro anticholinesterase potency.

However, there was no

correlation between in vitro anticholinesterase potency and their ability
to potentiate the muscle twitch elicited by the stimulation of the nerve or
. with their anti-curare activity.

Blaber then tested the action of these

compounds (neostigmine, edrophonium, methoxyambenonium, ambenonium)
for an action on the nerve terminal and showed that the duration of
repetitive discharges produced by close-arterially injected edrophonium
and neostigmine was approximately 50 milliseconds following each main
nerve spike.

This corresponded closely with the 'Cluration of the negative

after potential of the nerve terminal as recorded by Hubbard and S:hmidt

""' ------------------{ 1961}.
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Ambenonium was observed to cause antidromic firing for 300

milliseconds and methoxyambenonium was the only drug stu_9ied which,. by
itself, was unable to elicit antidromic activity in motor axons (Blaber and
Bowman, 1963B}.

Blaber concluded by suggesting that these compounds

potentiated the after potentials of the terminal, thereby giving rise to an
increased release of acetylcholine which prolonged the end-plate potential.
Depolarization of the end-plate and sensitization of the end-plate did not
contribute to the facilitating action of the compounds studied in Blaber' s
experiments.

The inhibition of cholinesterase seemed to be important

only in the case of ambenonium (Blaber, 1962}.
Werner ( 1961} using a divided nerve where the muscle action current
was too small to produce a back response in the nerve, demonstrated
repetitive activity in ventral root fibers following facilitatory agents.

These

data showed that the antidromic firing in the motor nerve was not a
consequence of the repetitive muscle action-currents.

Werner ( 1961} also

concluded that the time from the stimulus to the appearance of the
ephaptically induced back-response was considerably shorter than would
be expected if the site of initiation of the back-response was the motor
nerve terminal.

He therefore concluded that the ephaptically induced

back-response, was not initiated at the nerve terminals but at some
myelinated part of the intramuscular axons.

With the use of paired stimuli

in the presence of facilitatory drugs, Werner (1960 a) obtained data which
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5

uggested that the facilitatory agents augment the after potentials in the

nerve terminals and that the augmented negative after potential acts as a
current sink for neighboring parts of the axon, thereby generating
repetitive firing in the nerve.

Hubbard and S:hmidt (1961) substantiated

Werner's data using mic roelectrodes to stimulai::e the :1.erve te::.-minals.
Neostigmi-:-te in concentrations d 10 -? g/ml caused a reversible increase
in the refractory period of the nerve terminals and in the negative after
potentials.

The authors point out that the increased refractory period

probably indicates a prolongation of the spike potentials in the terminals,
suggesting that part of the effect of neostigmine on the end-plate potential
is caused by a prolongation of the period of transmitter release.
Recently, depolarizing compounds have been shown to have an action
on the motor nerve terminal (Adams, Deitrich and Gordon, 1963;
Edwards and Ikeda, 1962; Standaert, 1963; Standaert and Adams, 1965).
This phenomenon is similar to that following the administration of
anticholinesterase and related agents.

The non-ephaptic character of the

antidromic discharge is not as well substantiated as that of the anticholinesterases and part of the antidromic response to large doses of them
may be due to ephaptic conduction from the muscle to the terminal (Kato
and Fujimori, 1965).
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3:ill another compound which has been shown to have a terminal action
is curare.

/
Riker ( 1960) and S::andaert ( 1964) observed an antagonism by

d-tubocurarine of the lowering of the nerve terminal threshold by
acetylcholine.

This and the disappearance of antidromic firing induced by

hydroxyaniliniums after the administration of small doses of curare, caused
them to suggest involvement of the nerve terminal in the mechanism of
action of curare.
The effects of acetylcholine on the nerve t.erminal are pertinent with
regard to the nerve ter:r:ninal theory of drug action.

Hubbard, S:hmidt and

Yokota (1965) found no increase in the frequency of m. e. p. p. 's or in the
quantal content of the e. p. p. 's in the rat ph;renic nerve diaphragm preparation in which quanta! component of the e. p. p. was reduced by high
magnesium.

After neostigmine, acetylcholine decreased the quanta! content

of m. e. p. p. 's and still exerted no meaningful effect on the frequency of

-

acetylcholine release.

Yet, acetylcholine lowered the threshold of the

nerve terminal response to a cathodal pulse.

One set of experiments

seems to show that acetylcholine does not depolarize the terminal, while the
second set seems to imply that it does.

Hubbard suggested that acetylcholine

was depolarizing at the node or nodes of Ranvier.

The depolarizing effect

at this site was insufficient to increase acetylcholine release, but sufficient
to lower the threshold.

""'

...
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The purpose of the present experiments will be to attempt to show
/

how the compounds excite at the terminal location.

Do they stimulate

directly or is their effect mediated through acetylcholine?

Do the

depolarizers have a different mode of action at the terminal than the
facilitatory compounds?
at the terminal?
terminal?

What interaction exists between these compounds

Is there more than one site for drug action at the

These are some of the questions which we will attempt to answer

in the present work.

/

MATERIALS AND METHODS

,....
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I.

IN VIVO EXPERIMENTS
Experiments were performed on

?· 5

- 3. 5 kg. cats and tlfe elements

of the method employed are schematized in figure 4.
1. 5 mg. /kg. I. P. was administered to all cats.

Atropine sulfate

Ane thesia was instituted

by chloralose 60-80 mg. /kg. I. P. and 5 mg./kg. pentobarbital sodium.
The pentobarbital was used to decrease the initial stage of excitement due
to chloralose.

The animals were then fastened to the operating table in a

prone position and the trachea cannulated.

A polyethylene cannula was

placed iti the right carotid artery and connected to a Stratham pressure
transducer for the purpose of recording blood pressure.

To prevent

clotting, this cannula was filled with heparin dissolved in 0.
(200 units per ml. ).

9o/o

NaCl

Blood pressure was rec9rded to provide an index of

the animal's condition during the experiment.
A.

Preparation for the administration of drugs

The left jugular vein was cannulated for intravenous drug administration.

The polyethylene cannula was connected to a three -way stopcock

and clamped to a support on the operating table.

In experiments requiring

close arterial injection of the test drugs, Blaber's 1960 modification of
Brown's 1938 method was used.

The artery to the anterior tibialis muscle

was cannulated and the cannula filled with heparin solution {100 units per
ml.), plugged until ready for use and fastened to a support on the operating
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table.

For distal arterial injection of drugs the left femoral artery was
/

exposed on the posterior surface of the thigh and cannulated.

The cannula

was inserted until the end was approximately at the aortic illiac junction.
This was to insure that injections into this cannula would proceed into the
right leg.
B.

Recording of mechanical response

The right anterior tibialis muscle was exposed from mid-calf level to
its tendon insertion.
its i.nsertion.

The tendon was ligatured and cut from the bone of

Pointed drills 3/16 inch in diameter and 3 inches in length

were placed through the distal end of the femur, and the distal ends of the
tibia and fibula.

By means of the drills, the leg was mounted in a horizontal

plane to the operating table.
opening of the popliteal fossa.

This provided rigid fixation and permitted the
The fossa was then opened and the fat remov

Thread was passed around the femoral artery to permit occlusion for close
arterial injection via the tibial artery, thus assuring that the drug passed
into the tibialis muscle.

The tibial nerve was identified and isolated in the

fossa and extraneous connective tissue removed prior to placement on
platinum stimulating electrodes.

The common peroneal and sural nerves

were separated and cut distal to their junction with the sciatic to prevent
movement artifacts.

A shielded platinum electrode was placed on the

tibial nerve distal to the junction with the sciatic nerve and connected to a
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Bioelectric Instrument isolator which received pulses from a stir11ulator
/

consisting of a Tektronix type 162 waveform generator and a Tektronix
type 161 pulse generator.
mineral oil.

The pot-liteal fossa was then filled with warm

The ligature around the tendon of the muscle was connected

to a Grass model FT-10 force displacement transducer for the purpose of
recording mechanical twitch.

Rectangular pulses of 50~ sec. duration, and

twice the strength required to evoke a maximal muscle action potential were
applied once every 10 seconds through the shielded platinum electrodes
placed on the tibial ner_ve in the popliteal space.

Except where otherwise

stated the stimulating electrodes were placed so that the cathode was
nearest to the ventral root.

A temperature probe was placed in the belly of

the muscle and the muscle covered with a surgical sponge moistened with
mineral oil saturated with 0. 9o/o sodium chloride.

The muscle was

maintained at 37° C with heat lamps.
C.

Recording of muscle potential

Muscle potentials were recorded by means of a concentric needle
electrode.

The potentials were amplified by a Tektronix type 122 low-

level preamplifier and displayed on a Tektronix type 562 storage oscilloscope and photographed by means of a Tektronix 35 mm. camera or displayed
on a Tektronix type 502A dual beam oscilloscope and recorded on 35 mm.
film using an Analab oscilloscope camera using single frames or continuous
motion magazines.
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D.

Preparation of spinal cord

Laminectomy was performed to expose the lumbar cor/ A skin
incision of the back was made from L-3 to S-3.

Both sheets of the lumbar-

dorsal fascia were incised and the multifidus spinae muscle was removed
from L-4 to S-2.

The longissimi dorsi muscle was cauterized through on

both right and left sides at the level of L -7, but was not removed.

The

removal of the muscles was to cut down on fasciculations arising from

.

-drying as the experim~nt progressed and also to give more exposure in the
spinal area.

The vertebrae were then removed from L-5 through S-1

exposing the spinal cord and its coverings.

The dura mater was incised,

reflected and held by means of straight pins pushed into the longissimi
dorsi muscles at the L-7 level.
location of the spinal roots.

This maneuver raised the cord for easy

The L -7 root was is alated intra spinally and

the dorsal and ventral components detached from the cord.

The ventral root

was subdivided until an afferent tibial filament was located by monitoring
the nerve potential with an oscilloscope.

The skin edges around the

exposed spinal cord were elevated to form a pocket which was filled with
warm liquid paraffin saturated with 0. 9o/o sodium chloride..

The spinal oil

pool was kept warm by means of a heat lamp.
E.

Recording of nerve potential

Nerve potentials were recorded by placing a selected portion of the
ventral root on bipolar platinum electrodes 5 mm. apart.

The potentials
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were amplified by a Tektronix type 122 low -level preamplifier and displayed
/
on a Tektronix type 562 storage oscilloscope and photographed by means
of a Tektronix 35 mm. camera or displayed on a Tektronix type 502A dual
beam oscilloscope and recorded on 35 mm. film using an Analab oscilloscope camera with single frames or continuous motion magazines.
F.

Experimental procedure

The blood pressure, muscle twitch, and temperature were all
monitored on an Offner type R dynograph.

After amplification by a

Tektronix type 122 pre-amplifier, the muscle and nerve action potentials
were monitored simultaneously on a Tektronix type 562 double beam storage
oscilloscope and photographed on 35 mm. film.

There was a 30 minute

.

control period of muscle twitches prior to the 'injection of drugs.

After this

control period test compounds were given either intravenously, closearterially, or distal arterially.

These were given either in the presence of

indirect stimulation (1/10 sec. or in some experiments 100/sec. /150M sec.
10 sec.) or without stimulation.
All drugs injected were dissolved in 0. 9% sodium chloride.

0. 9%

sodium chloride was also used to wash the cannula after i. v. injections.
A solution containing 100 units heparin/ ml. was used to wash the close
arterial cannulae after injection.
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II.

IN VITRO EXPERIMENTS {MICROELECTRODE)
The. usual techniques were employed for intracellular recording with
/

capillary glass microelectrodes (Fatt and Katz, 1951}.

Electrodes of

between 5 and 15 M ohms resistance were used and special attention was
paid to keeping the input time-constant of the recording circuit as small as
possible.
The tenuissimus muscle of the cat was removed from the anaesthetized
animal and mounted in a c.onstant temperature bath.

The chamber for the

muscle and bathing fluid was constructed of plexiglas.

The temp-erature

was maintained at 37° C with the use of a Haarke constant temperature
circulation pump.

The muscle was bathed in prewarmed oxygenated

Krebs's solution (Boyd and Martin, 1956) to which was added 30 ml. /L
of isotonic glucose solution (final composition:

sodium chloride, 115 mM;

KC 1, 4. 60 mM; KH2P04, 1. 15 mM; NaHC0 3 , 24. 1 mM; CaC 12, 2. 46 mM;
MgS04,

1. 15 mM; glucose, 8. 85 mM}.

Oxygenation was effected by

bubbling a 95o/o-5o/o C02 mixture into the solution before it passed into
the muscle bath.

The bath had a volume of 3 ml. which was. changed

continuously at a rate of 200 ml. /hr. by dripping in fresh fluid and
allowing the excess to overflow on one side to maintain a constant level.
Superficial nerves were located visually and the end-plate located by
the position where them. e. p. p. 'shad the greatest amplitude and shortest
time course.

~
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The drugs used, succinylcholine and decamethonium were added to
/
the control Krebs' solution to give the appropriate concentration.

The

level of drug was increased by increments of 10 fold from 10-1 2 M until
the end-plate depolarized.

Them. e. p. p. 's were amplified using a

Nikkon hi-input impedence D. C. amplifier and a Tektronix 122 low .,.level
A. C. preamplifier.

They were monitored and photographed on a Tektronix

502 dual beam oscilloscope until depolarization occurred.

Each concen-

tration was infused for 10 minutes before any recordings were made.

~
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Drugs and SJlutions:
/

Atropine fulfate- (Matheson Coleman & Bell) SJlutions were made up in
0. 9o/o sodium chloride to contain 10 mg. lml.
Pentobarbital SJdium (Abbott Laboratories) 50 mg.

I ml.

a-Chloralose (City Chemical Corporation of New York) SJlutions were
freshly prepared in 0. 9o/o sodium chloride to contain 10 mg.

I ml.

Heparin SJdium (Aero Chemical) SJlutions were made up in 0. 9o/o sodium
chloride to contain 100 and 1000 units lml.
Neostigmine Bromide (City Chemical Corporation of New York) SJlutions
w<tre made up to contain 1 mg.

I ml.

Edrophonium (Hoffmann LaRoche {Tensilon) ) SJlutions were made up to
contain 1 mg. lml.
Ambenonium {Sterling-Winthrop (VVIN 8077) ) Solutions were made up to
contain 1 mg.

I ml.

Methoxyambenonium (Sterling-Winthrop (WIN 8078) ) Solutions were made up
to contain 1 mg.

I ml.

Decamethonium Bromide (Burroughs Wellcome (Syncurine; C10))
were made to contain 1 mg.

Solutions

I ml.

fuccinylcholine Chloride {Travenol) Solutions contain 20 mg. lml.
Acetylcholine Chloride {Merck) Solutions were made to contain 1 mg.

I ml.

Choline Chloride {Abco Chemical) Solutions were made up to contain 10
,____m_[: lml.

-
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Tubocurarine Chloride {Abbott)
Hemicholinium (HC -3)

3 mg. /ml.

(Dr. J. P. Long, University of Iowa}' Solutions

were made up to contain 10 mg. /ml.
~~", c2:"1t\'iLC1\o~
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I. EFFECTS OF S:NGLE DRUGS
--

/

The production of antidromic motor nerve discharges in the presence
or absence of orthodromic stimulation following the administration of
facilitatory and depolarizing drugs has been previously reported (Masland
and Wigton, 1940; Feng and Li, 1941; Riker, et. al., 1959; Werner,
1960 a & b; Blaber, 1962; Blaber' and Bowman, 1963 a & b; Standaert, 1963)
and has been discussed in the introduction to this thesis.

In this section

the drugs neostigmine, edrophonium, ambenonium, methoxyambenonium,
succinylcholine and decamethonium have been tested for their ability to
produce this effect.
A.

The effect of facilitating and

d~polarizing

drugs following

s timulation by a single volley
In these experiments single nerve shocks were delivered at intervals
of 10 sec.

A typical record of muscle and ventral root action potentials in

re-sponse to a single :nerve stimulus is illustrated in figure 5.

The anti-

dromic nerve spike in response to the stimulus was followed, about 2 msec.
later, by a brief burst of small spikes which terminated about 5 msec.
after the stimulus artifact.

This secondary back discharge has been shown

not to be directly elidted by the stimulus in the more slowly conducting
fibers, such as the gamma-efferents, since it was completely abolished
by cutting the nerve between the stimulating electrodes and the muscle
(Blaber,

1962).

,..-·
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FIGURE 5

/

L
_J;l
_____
2. 6 kg. Cat - Muscle action potential (upper trace) recorded from the
tibialis muscle with concentric needle electrodes, and nerve action
potential (lower trace) recorded antidromically from the ventral root.
Voltage calibration: muscle SmV, nerve 100 ,uV; time calibration: 10 msec.
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The presence of the back discharge is, therefore,

clearly dependent

on activity in the muscle and corresponded to the ephaptic bae'k response
described by lloyd (1942) and, more recently, by Brown and Matthews
(1960).

As shown by Brown and Matthews (1960) the back response in the

nerve would occasionally re-excite some of the muscle fibers.

Observation

of the response depended upon the position of the needle electrode.

The

ephaptic back response as seen in the ventral root was most clearly seen
·with monophasic recording since with diphasic recording it is partly
obscured in the positive deflection of the main antidromic spike.

When the

single stimulus applied to the nerve is reduced in intensity so that a submaximal muscle response is produced, the back response in the nerve
becomes progressively smaller and eventually disappears at a time when the
muscle action potential is still approximately one half of its maximal size.
This confirms the observations of Brown and Matthews that the summed
action currents of almost all of the muscle fibers are necessary to
ephaptically excite the motor nerve fibers.
Close -arterial administration of neostigmine (2 ,ug), edrophonium
(5 ,ug), or ambenonium (2 ,ug) or intravenous administration of succinylcholine (35 ,ug) or decamethonium (35 }..lg} caused , following orthodromic
stimulation, the appearance of high frequency antidromic discharges in
the ventral root ace ompanied by repetitive firing of the muscle fibers.
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These effects are illustrated in figures 6 and 7.

The first nerve spike in

/
the repetitive train appeared between 5-10 msec. after the main antidrcrnic

spike.

In the cases of ambenonium, edrophonium, and neostigmine the

firing was asynchronous and at the height of the effect had a time course of
approximately 50-100 msec. following the injection of edrophonium and
neostigmine, and 200-300 msec. after an injection of ambenonium.

The

firing, following each nerve spike, was observed to be present for 5-10
minutes after edrophonium, for 30 minutes after neostigmine, and for 45
minutes following ambenonium.

The firing following an injection of

decamethonium or succinylcholine was more synchronous than that of the
above compounds and had a time course of approximately 100 msec.
following each main nerve spike.

The ephaptic response with these two

compounds was greatly enlarged, sometimes to more than 400o/o of its
original height.

There was usually a slight block of the muscle twitch with

the doses used, and the ephaptic response at this time would diminish and
eventually disappear in many cases.

However, antidromic firing was

still present following the nerve spike.

As the muscle proceeded into

block this activity changed from a synchronous firing to one which
resembled that obtained after an injection of one of the facilitatory compoul'Xi'3
This firing was present until the muscle was at maximal block and then
disappeared slowly.

These effects may be seen in figure 8.

A slight

,....
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FIGURE 6
I
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I

I
:q'

~l;te
a . ./
3. 7 kg. Cat -Antidromic nerve potentials recorded in the ventral root
following a single nerve stimulus. a) Control; b) following 45 ,ug
succinylcholine i. v.; c) 2 minutes later. Voltage calibration:100 uV;
time calibration: 10 msec.

FIGURE 7
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4. 6 kg. Cat - Antidromic nerve potentials recorded in the ventral root following
a single nerve stimulus. a) Control; b) 5 ,ug edrophonium; c) 20 minutes
laterc.a:Voltage calibration: 100 ,uV; time calibration: 10 msec.
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FIGURE 8
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d.

2.4 kg. Cat- Antidromic nerve potentials recorded in the ventral
root following a single nerve stimulus. a) Control; b) 20 ,ug decamethonium
i. v.; c) 1 minute later; d} 2 minutes later after b. Voltage calibration: 100 ,uV; time calibration: 10 msec.

~------------------------------------------------·---6-9-,
asynchronous activity can be observed during the synchronous or
/
facilitating phase of the depolarizing compounds and in the initial phase
of the neuromyal block.

The asynchronous activity became more apparent

due to the disappearance of synchronous firing.

As the muscle twitch

returned to control height following blockade by the depolarizers, antidromic firing in the nerve was not' observed and the ephaptic response was
not potentiated from that of control.
Methoxyambenonium

(? -20

,ug) did not produce repetitive firing either

on the muscle or the nerve confirming the results of Blaber andBowman

(1963

a).

However, in some cases the muscle twitch was slightly

potentiated.
B.

The effect of facilitatory and deeolarizing drugs in the absence
of nerve stimulation

In these experiments single nerve shocks were delivered at intervals
of 10 seconds as in the previous experiments, but discontinued shortly
before the drug was to be administered.

A typical record of muscle and

ventral root activity in response to ambenonium is shown in figure 9.

The

resting activity of the muscle and nerve was increased considerably in this
case in the absence of electrical stimulation.

This activity is concluded

to be a direct action of the drug at the neuromuscular junction.

0
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d.
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3. 1 kg. Cat - Muscle potentials (upper trace) and antidromic nerve
potentials recorded in the ventral root {lower trace) in the absence
of nerve stimulation. a) At a. 2 ,ug ambenonium c. a.; b) 15 sec.
later; c) 15 minutes later; d) 30 minutes later; e) 60 minutes later.
Voltage calibration: 50,uV, muscle . 25 mV; time: l second.
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Oscilloscope recordings were photographed on 35 mm. film,. and
/
indirect stimulation was restarted and continued until it was tlme for the

next injection.
Neostigmine and Edrophonium
These compounds in doses of 5 p.g (total dose} were capable of
eliciting activity in the nerve and the muscle in the absence of electrical
stimulation.

The.response occurred 3-4 seconds after injection of these

compounds and lasted several minutes, after which a decrease in amplitude
of the spikes occurred and slowly faded to control levels.

It appeared that

the decrease in amplitude was more pronounced than the decrease in
frequency of spikes as the effect of the

dru~

wore off.

The effect on the muscle was not as pronounced as that on the nerve.
The spikes which occurred faded much faster than those of the nerve.
At any time during direct action of the compound if an indirect
stimulus was applied the nerve and muscle activity was potentiated
amplitude and frequency.

~n

However, it is difficult to determine if the effects

of the drug in the junctional region were prolonged.
Ambenonium
This drug in doses of 2 p.g (Total dose c. a.) produced a similar
action to that of neostigmine.

There was a longer latency {15 sec.) after

the injection of the drug before activity was noticed on the muscle and
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nerve.

When activity started it was of a higher amplitude and greater
/

frequency than that observed with neostigmine.

The direct effect of the

drug on nerve and muscle potentials lasted for more than one hour before
fading to a resting level of activity.

This compound proved to be capable

of producing the greatest magnitude of activity at the junction of any of the
compounds studied in these ecperiments.

The activity on the nerve and

muscle could, as with neostigmine, be potentiated with indirect stimulation.
The animals were observed to show symptoms of anticholinesterase
poisoning after this compound, such as salivation, fasciculations throughout
the entire animal and, in some cases, urination.
Succinylcholine and Decamethonium .
The direct action of these compounds on nerve and muscle action
potentials did not seem to differ in form from the anticholinesterase
compounds as it did after indirect stimulation.

At the dose level used

(0. 5 ,ug total) there was firing present in the nerve and muscle after a
latent period of 3-4 seconds.
The activity was not present at a constant level as it was with
neostigmine or ambenonium.

It appeared to be a "bursting" type of

.

activity, i.e., short periods with a decrease in amplitude followed by an
increase in: amplitude period.

However, the activity does not change in

character as does the activity following orthodromic stimulation.

In the
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absence of orthodr01nic activity the nerve response is like that produced by
the anticholinesterase compounds and it does not disappear due to any .
blockade.

At higher dose levels no activity in the nerve was observed but,

in contrast to the fasciculations produced at the lower dose, the muscle gave
an immediate twitch-like response accompanied by a burst of asynchronous
muscle potentials.
Acetylcholine
The direct action of acetylcholine on the nerve terminal was tested
using three methods.

Intravenous injections produced no response.

The

close arterial administration of acetylcholine at doses ranging from 0. 01 to
50 Mg c. a. produced no more than a short burst of activity in the ventral
root.

The muscle response was somewhat longer.

This was true whether

it was administered in the presence or absence of orthodromic stimulation.
It has previously been reported that direct firing was observed

following distant arterial injection of 100 J.1 g of acetylcholine (Masland and
Wigton, 1940).

Direct firing did result following distant arterial adminis-

tration of acetylcholine in the femoral artery at a dose of 50 pg, which is
considerably less than that previously reported.

However, this firing was

not of the amplitude nor duration seen with the other depolarizing compounds
~nee

it was a d. a. injection the possibility existed that acetylcholine was

hy-drolyzed before it r·eached the effector cell and that choline was actually

,--~----------------------------------------~-------------------------------------,
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stimulating the nerve.

An equivalent amount of choline {38. 5 :1-1g) was

injected and caused no observable effect in the nerve.

/
The muscle twitch

increased following injection of acetylcholine and then fell to below control
level which lasted approximately 30 minutes. {See figure 10).
Methoxyambenonium produced no antidromic discharge when administered alone.

However, whm it was followed by one of the other facilitatory

agents, antidromic discharges were produced following a greater number
of orthodromic stimuli compared with the administration of the facilitatory
agent alone.

The magnitude of the muscle twitch was potentiated over that

produced by the facilitator alone.
The duration of the nerve terminal response was noticeably increased
in the methoxyambenonium-edrophonium combination, lasting almost 30
minutes, which is approximately twice what would be expected with
edrophonium alone.
The combination of a facilitatory drug and a depolarizing compound
caused an increase in the magnitude of the nerve terminal response
following orthodromic stimulation.

However, with the exception of

methoxyambenonium, this combination shortened the duration of the responsE
when compared with that produced by either drug in the combination.

This·

was most likely due to an increase in onset of neuromuscular blockade
produced with the combination.

The block was faster in onset, increased

75
FIGURE 10
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3. 3 kg. Cat - Muscle potentials (upper trace and antidromic nerve
potentials recorded in the ventral root (lower trace) in the absence of
nerve stimulation. a) 50 .ug d. a. acetylcholine; b) 10 sec. later;
c) 1 minute later. Voltage: nerve 50 .uV, muscle . 25 mV; time:
1 second.
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in depth and duration compared to the blockade produced with the depolarizer
alone.

/

The activity produced in the presence of orthodromic stimulation
was greatest in magnitude and shortest in duration following the neostigmine
decamethonium combination.

The increase in magnitude was least pronounc

following the edrophonium-succinylcholine combination.

However, the

duration of activity was longest in the methoxyambenonium-succinylcholine
combination lasting for over 30 minutes while it was shortest following the
administration of neostigmine-decamethonium lasting less than 5 minutes.
It should be stated that the term "magnitude" in the context in which it

is used in this thesis refers to both the amplitude and duration of an antidromic response.
The terms "asynchronous" and

11

synchronous" were applied following

visual comparison of the duration of single repetitive nerve spikes in
different antidromic response trains.
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II.

INTERACTION AT THE NERVE TERMINAL
A.

Combinations of the test compounds

/

When the facilitatory agents were administered in combinations with
one another the effect was an increase in magnitude and a prolongation of
the nerve terminal response when compared to the administration of either
drug alone.

This was true whether orthodromic stimulation was applied or

not. (See figure 11).
The increase in nerve terminal response was not as pronounced though
for all combinations.

~mbenonium

inducer of antidromic firing.

was, as mentioned previously, a potent

In combinations with other compounds a

prolongation of activity was not markedly i!lcreased over ambenonium
alone.

The amplitude of the response was initially increased and this

increase lasted for approximately 20 minutes with edrophonium, 30 minutes
with neostigmine, and 45 minutes with methoxyambenonium, although with
the latter compound the increased magnitude was not as great as with the
other compounds.

The duration of nerve terminal firing lasted 40-50

minutes when ambenonium was given with another facilitatory agent which
was approximately the same duration as when ambenonium was given alone.
In the absence of stimulation, combinations of facilitatory and
depolarizing compounds did not cause a shortening of either one's action.
In this situation an increase in magnitude of response was accompanied
by an increase in duration with, once again, the exception of methoxyam-

FIGURE 11

/
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2. 6 kg. Cat - Antidromic nerve potentials recorded in the ventral
root following a single nerve stimulus.
a) Control; b) 1 .u g neo_stigmine c. a.; c) control; d) 5 .ug edrophonium c. a.; e) 1 .ug
1_1eostigmine c. a. followed by edrophonium c. a. Voltage calibration:
100 .u V; time:'lO msec.

•,

..
79
benonium (figure 12).

In the absence of orthodromic stimulation the

magnitude was the greatest and the duration longest in the ambenonium/
decamethonium combination and the magnitude least and duration shortest
in the edrophonium-succinylcholine combination.
Methoxyambenonium is of particular interest here because it has been
reported to antagonize decamethonium paralysis in the cat, as well as
tubocurarine paralysis (Karczmar, 1957).

Methoxyambenonium was

injected 5 ,ug intra-arterially 2 minutes previously to depolarizers which
were given intravenously in doses (35 ,ug), sufficient to reduce the twitch
tension of the tibialis anticus muscle by approximately 40%.

In the presence

of orthodromic stimulation this combination caused a lessening of the
paralysis caused by the depolarizer alone.

The antidromic firing on the

root was increased in magnitude and more prolonged following this combination than with the depolarizer alone (figure 13).

This antagonism of

blockade ~ould agree wilh Blaber' s and Karc zmar' s ( 1967) experiments
showing reversal of depolarizing paralysis by certain doses of methoxyambenonium.
Another finding in these experiments which was particular to
methoxyambenonium was the antagonism of the direct nerve terminal
response to depolarizers.

When given alone it has been shown that they

produced firing in the ventral root.

It was stated above that methoxyam-
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FIGURE 12

c.

3. 4 kg. Cat - Muscle potentials (upper trace} and antidromic nerve
potentials recorded on the ventral root (lower trace) in the absence
of nerve stimulation. a) Control; b) 0. 5 ,ug C 10; c) 0. 5 ,ug C 10
and 5 pg neostigmine. Voltage calibration: nerve 50 ,uV, muscle
. 25 mV; time: 1 second.

FIGURE 13
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4. 6 kg. Cat -Antidromic nerve potentials recorded in the ventral root
following a single nerve stimulus. a) Control; b) 45 pg succinylcholine
i. v.; c) 2 pg methoxyambenonium i. a.; d) 45 pg succinylcholine i. v.
2 minutes after c.; e) 30 minutes after d. Voltage calibration: 50 J.l v;
time calibration: 10 msec.
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benonium in combination with depolarizers potentiates the response following
orthodromic stimulation.

However, in the absence of orthoc(r01nic stimu-

lation methoxyambenonium administered previous to a depolarizer caused
blockade of nerve terminal firing {figure 14.).

However, it will be noticed

that the repetitive firing on the muscle was not changed with this combination.
This block lasted for nearly an hour before backfiring could be induced by
the depolarizer.
Methoxyambenonium was also administered distal arterially {20 ,ug)
previous to a dose of acetylcholine (50 ,ug} which was shown to induce
repetitive firing in the terminal in the absence of indirect stimulation.

This

dose of methoxyambenonium caused no nerve terminal or muscle repetitive
firing but did increase the amount of firing in amplitude, frequency and
duration following acetylcholine.

Neostigmine {100 ,ug) which also caused

spontaneous firing distal arterially, increased the response to acetylcholine
in the same way as methoxyambenonium.
- B.

Effect of transmitter depletors

No substance is known to inhibit specifically choline acetylase after
systemic administration, although larger amounts of any inhibitors of
other enzymes may do so to some extent {Berman-Reisberg, 1957).

An

important series of compounds known to reduce acetylcholine synthesis are
the hemicholiniums.

These were synthesized by Long and frhueler in 1954.

The most active member of this series is hemicholinium No. 3 (HC -3).
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FIGURE 14
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. 3. 0 kg. Cat- Antidromic nerve potentials recorded in the ventral
root in the absence of nerve stimulation. At a) 0. 5 ,ug .decamethonium
c. a.; b) follows a; c) 5% ,ug c.a..methoxyambenonium; d) 0. 5 ,ug
decamethonium c. a. 2 minutes after c. Voltage calibration:
nerve 20 p. V, muscle . 25 mV; time calibration: 1 second.
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During prolonged tetanization at 10-20/sec. of muscles treated with HC-3,
/
there is a progressive and severe diminution of the miniature e. p. p. 's

virtually to extinction and there is a parallel diminution of the e. p. p. 's
(Elmqvist, Quastel and Thesleff, 1963).

It seems likely that this action

of HC -3 is a demonstration of a reduction in the quantal size of acetylcholine
Nerve stimulation is required for HC -3 to effect a blockade of cholinergic
transmission in situ and, further, there appears to be a direct relationship
between degree of depression and frequency of stimulai:ion (Wilson and
Long, 1959; Chang and Rand, 1960; Wong and Long, 1961).

A striking

characteristic of the transmission failure produced by HC -3 is the marked
antagonistic ability of choline.

HC -3 is

be~ieved

to act by combining with,

and thereby temporarily inactivating, the choline -carrier mechanism which
is responsible for transporting extra-cellular choline across the membranes
of cholinergic nerve -endings to the intracellular sites of its acetylation
(Gardiner, 1957; Macintosh, 1961; Birks and Macintosh, 1961).

Thus,

HC-3 renders the nerve terminals deficient in choline and, therefore, in
acetylcholine.

This then causes the block which is characteristically slow

in onset and dependent on the frequency of stimulation of the nerve.
HC -3 also has been shown to cause neuromuscular block by acting as
a curarizing agent when applied to rat or frog muscles in vitro, decreasing
their sensitivity to directly applied acetylcholine and also decreasing the
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size of the m. e. p. p. 1 s without affecting their frequency or the quantal
numbers of the e. p. p. 's produced by nerve stimulation (Martin and
Orkand, 1961; Thies and Brooks, 1961).
Another mechanism of action of HC -3 has been proposed recently;
Hart and Long (1965) were unable to detect any significant differences in
tissue levels of acetylcholine after HC-3 administration and though that
an anti-release mechanism for the compound 3hou1d be CO)lSidered.
<

Other compounds have been shown to exhibit actions similar to
those of HC -3.

An extensive investigation was carried out by Bowman

and his associates with regard to the triethyl-analogue of choline, N -triethylamino ethanol

(triethyl 2-hydroxyethyl-ammonium, triethylcholine, TEC::).

TEC produces a failure of neuromuscular transmission; the rate of onset
and degree of paralysis increases with increasing frequency of stimulation.
The blockade by TEC is reversed by an excess of choline and TEC also
possesses a weak curare-like action (Bowman and Rand, 1961).

All

this points to a possible mechanism of action like that of HC -3.

n·

has been shown in vitro (Burgen, Burke, and Desbarats-Schonbaum,l956)
that TEC is readily acetylated by the enzyme, choline acetylase.

The

nerve terminal, therefore, may accept TEC in place of choline and
liberate an inactive transmitter ("false transmitter").

However, Hemsworth

and Morris (1964) were unable io confirrn these findings.

One of the strange

effects of TEC is that neuromuscular failure produced by TEC is often
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preceded by an increase in the amplitude of twitch and the compound is
thought to initially increase the output of acetylcholine (Bowrrtan, et. al.,
1962).
In the following experiments the effects of intravenously injected
HC -3 (I mg. /kg.) and TEC (25 mg. /kg.) during various stimulating
frequencies were studied.

Some general observations which apply to all

stimulus frequencies can be made at the outset.

TEC was observed to

cause a slight potentiation of the muscle twitch for a short time after its
administration; however, this was not observed to cause any activity on
the ventral root.

HC -3 did not cause an increase in twitch nor was there

any observable antidromic firing on the nerve terminal with this compound
alone.

HC -3 did cause appreciable fall in blood pressure upon its

administration which leveled out after 2-3 minutes.
Choline (5 mg. /kg.) was used in many cases to antagonize TEC or
HC -3 blockade.

Choline proved a much more effective antagonist of TEC's

activity than it did of HC-3 1 s.

It did, however, antagonize HC-3 blockade

but in some cases two doses were required to bring the muscle twitch back
to control levels.

Choline itself was never observed to cause any anti-

dromic firing.
3:imulating 1/10 sec.
HC -3 (1 mg. /kg.) had no effect on the drug induced firing following
orthodromic stimulation in the case of depolarizers and facilitators.

We
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would not expect acetylcholine depletion with this stimulus frequency, but
it was necessary to test the reported curare effect of HC -3 to

~ee

if it

could antagonize nerve terminal firing.
Stimulating 1/sec.
At this frequency of stimulation we would expect HC -3 and TEC to
produce muscle block.

This was the case.

Depolarizers or facilitators,

however, produced antidromic firing, resembling the control activity,
immediately following the injection of TEC or HC -3, which in all cases
diminished as the block became maximal.
mately 20 minutes for TEC

a~d

The time for this was approxi-

90 minutes for HC -3.

After the adminis-

tration of choline {5 mg. /kg. i. v.) or after the effect of the HC-3 and TEG
had worn off, control level firing was obtained.

It should be stressed that,

in some cases, as shown in figurel5 the total block of the muscle {which
only occurred in the case of HC -3) did not completely abolish nerve
firing. In this figure we can observe the synchronous firing of succinylcholine changing to asynchronous during total blockade of the muscle twitch
by HC -3.

There was no ephaptic response present during this time.

In

other cases the firing was not present during block nor could it be
observed after a return to control twitch height.
did not return to control twitch levels.

In many cases the muscle

At this frequency of stimulation

HC -3 had other variations of response, i.e., in some cases it blocked the
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FIGURE 15

/

L
-'·

a.

c.

b.

d.

2. 9 kg. Cat Antidromic nerve potentials recorded in the ventral root following
a single nerve stimulus. a) Control; b) 30 ,ug succinylcholine i. v. ;
c) 30 Ag succinylcholine i. v. at 50% paralysis following 1 mg/kg
hemicholinium i. v. ; d) 30 Ag succinylcholine i. v. at 95% paralysis
following 1 mg/kg hemicholinium i. v. Voltage calibration: 100 AV;
time calibration: 20 msec.
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appearance of antidromic firing with partie ular com pounds, and in other
/

cases it did not.

The synchronous firing was not always inhibited so that

the asynchronous was unmasked.

For these reasons a higher rate of

stimulation was used to produce a faster block with the same dosage of
HC -3.

This allowed a more constant experimentation to be carried out.
Stimulating at 100/sec. for 150 msec. once every 10 sec.
Under these conditions a constant series of nerve action potentials

like those shown in figure 16 is produced.

Ventral root activity is inter-

preted as a depression in the train of impulses (Blaber, 1962).

The

depression of the spikes in the train is due to extinction of the nerve action
potentials through collision with the back firing in the nerve.

Typical

responses to close-arterial injections of neostigmine and succinylcholine
are shown in figures 16 and 17.

The depression of spikes occurred upon

the injection of these agents prior to and immediately following an intravenous dose of either TEC or HC-3.

However, as the time between the

administration of the inhibitory drug and that of the test agent was increased
the nerve terminal activity dec rea sed in a direct relationship with the blockade of the muscle twitch.

There was no depression of spikes (i.e., no anti-

dromic firing) following c. a. injections of either anticholinesterase or
depolarizing agents during the period of maximal blockade of TEC. and
HC -3.

Maximal blockade of muscle twitch occurred about 60 minutes after
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FIGURE 16

/
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c.
2. 7 kg4 Cat ... Antidromic nerve potentials recorded in the ventral
root in response to a tetanic stimulus. a) Control; b) .following
edrophonium 5 p.g c. a. Between band c triethylcholine 25 mg/kg
i. v. was administered. c) Following edrophonium 5 p.g c. a. at
95% paralysis due to the triethylcholine. Voltage calibration:
0. 5 mV; time calibration: 20 msec.
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FIGURE 17

/

b.

a.

c.

3. 1 kg. Cat - An1idromic nerve potentials recorded in the ventral
root in response to a tetanic stimulus. a) Control; b) following
succinylcholine 0. 5 }.lg c. a. Between band c hemicholinium
1 mg/kg was administered. c) Following succinylcholine 0. 5 ,ug
c. a. at 95% paralysis due to the hemicholinium. Voltage calibration: 20 ,u V; time calibration: 20 msec.
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the administration of HC -3 and 20 minutes after TEC.

TEC and HC -3 were
/

discovered to have an unreported action at this stimulation frequency
which is important when considering the effects of drugs on the nerve

•

terminal.

It was observed that a progressive increase in the amplitudes

of the spikes, recorded from the ventral root, occurred after the administration of these compounds which reached a maximal height at the time of
greatest blockade.

This, for lack of a better explanation, was interpreted as

a hyperpolarizing action.· This phenomenon can be seen in these figures.
Immediately following the injection of choline a return to controls
levels of the muscle and nerve was obtained and the facilitatory and
depolarizing agents again showed nerve terminal actions.
In some cases the HC -3 action outlasted that of the choline and the
musCle would return into blockade, corresponding to the twitch height
it would have been at if no choline had been given.

The antidromic activity

was again reduced.
C.

Tubocurarine

Small doses of tubocurarine injected close-arterially (1 ,ug at the
height of the effect of the facilitatory drugs did not abolish the repetitive
firing in the ventral root.

Larger amounts of the blocking drug (5 ,u g

given close-arterially} did partially antagonize the antidromic firing from
the terminal. However, this was short lasting (20 minutes} and it was
decided that larger intravenous doses should be tried.

One hundred ,ug
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curare administered i. v. before the administration of a facilitatory agent
or depolarizing com pound abolished the repetitive firing in lSoth the ventral
root and the muscle produced by these agents (figure 18).

This amount of

curare produced depression of the muscle twitch by approximately 20%.
A further dose of a facilitatory or depolarizing compound given within
the next 45-60 minutes did not restore the repetition.

This finding

confirms that the main blocking action of curare is post synaptic.
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FIGURE 18

. c.

2. 9 kg. Cat - Muscle action potentials (upper trace) and antidromic
nerve action potentials recorded in the ventral root (lower trace) in
the absence of nerve stimulation. At a) decamethonium 0. 5 pg c. a.
was injected. Tubocurarine 100 p.g i. v. was administered 2 minutes
before b. At b) 0. 5 pg decamethonium c. a. was administered.
c) 30 minutes after b. Voltage calibration: nerve 50 p.V, muscle
. 25 mV; time calibration: 1 second.
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III.

MICROELEC TRODE STUDIES
This phase of the research was carried out to test )Yhether

~

.

succinylcholine and decamethonium were depolarizing the nerve terminal.
Katz (1962) concluded that m. e. p. p. frequency is controlled entirely by
the conditions of the presynaptic membrane.

Liley {1956) showed that a

tenfold increase in frequency of them. e. p. p. could be expected from a

15 mv. depolarization of the nerve terminal.
In four experiments neither decamethonium or succinylcholine
produced any readily observable change in frequency, amplitude, or rise
time of m. e. p. p. 1 s at concentrations ranging from 1o-1 2 molar to 10- 6
molar.

The frequency varied throughout the experiment but it is unlikely

that any changes were drug induced.{See Liley, 1956).

The amplitude of

m. e. p. p. 1 s diminished as the end-plate membrane was depolarized
{Table 1).

Decamethonium depolarized the end-plate at 10- 7 molar while

succinylcholine depolarized at 5 X 10- 6 molar.

This shows them to be

potent depolarizers of the end-plate when one considers that acetylcholine
depolarizes at approximately 10-3 molar (Blaber and Christ", 1967}.

It

may be concluded that succinylcholine and decamethonium do not depolarize
the motor nerve terminal.

TABLE 1-A
/

Effects of Succinz:lcholine on M,e•E•2•s
Frequency
of
Rise-time
(msec)b

Half-decay

tsec- la

Amplitude
tmV) b .

~msec)b

Membrane
Potential
tmV}

1. 7. t 0.1

o.s t o.1

0.7 t 0.4

1.2 t 0.2

75

1o-10

2.0 :!: 0.1

o.s t 0.1

0.7 t 0.1

1.0 t 0.2

77

to- 9

.1.9 :!: 0.1

0.5 + 0.1

-

0.7 + 0.1

1.1 + o.t

78

-

-

2.2 + 0.1*

o.s :!: 0.1

0.7 :!: 0.1

1.2 t 0.2

80

2.2 t 0,1*

0.4 t 0.1

o.8 :!: 0,1

1.1 t 0.1

80

Concentration
of
Succinllcholine ~Ml

m.e.p.~.s

Control

!

·Jo-8
'

5

X

10- 8
to-7

70

TABLE 1-B
Effects of Decamethonium on M.e•2•2•S

Concentration
of
Decamethonium ~M)

5

l

~

.Frequency
of
m.e.p.~.s

~sec-

Amplitude
~mVlb

Rise-time
~msec) b

Half-decay
(msec) b

)a

Membrane
Potential
(mVl

Control

2.1 t 0.1

o.8 t 0.2

0.6 t 0.1

1.2 t 0.1

68

to-9

1.8 t 0.1

0.6 t 0,2

0.6 t 0.1

1.2 + 0.3

-

65

to- 8

1.9 t 0.1

0.6 + 0.2

-

0.7 t 0.1

1.0 + 0.2

-·

68

lo- 7

2.1 t 0,1

0.7 + 0.2

-

0.7 t o.t

1.1 t 0.2

70

X

lo- 6

53

a

t Standard error of the mean.

b

:!: Standard deviation.

*

Difference statistically significant at the 0.1% le el as compared
to the control.

II
I

M.e.p.p.s too small to measure accurately.

DISCUSSION
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I.

EFFECTS OF S:NGLE DRUGS
/

A.

The effect of facilitatory and depolarizing drugs following
stimulation by a single volley

The.results of the present investigation have confirmed the results
of Blaber and Bowman ( 1963 a) that edrophonium, neostigmine and
ambenonium produce antidromic firing in the motor nerve following
orthodromic stimulation.

No antidromic firing was observed in the

presence of methoxyambenonium also

confirmi~g

the results of Blaber

and Bowman.
Antidromic firing was also observed in the presence of succinylcholine and decamethonium following ortho?romic stimulation.

However,

the response differed from that produced by the facilitatory drugs in that
'

it was more synchronous.

.

The ephaptic response was increased in

amplitude in some cases to more than four times the control height.

As

the muscle became paralysed the synchronous firing disappeared leaving
only asynchronous firing which resembled very closely the antidromic
firing produced by the facilitatory drugs.

Brown and Matthews ( 1960)

concluded from their experiments that the synchronous stimulation of all
the muscle fibers was required to elicit the ephaptic

~espouse.

Blaber

and Bowman (1963 a), however, showed that the antidromic firing
produced by the facilitatory drugs continued when the muscle was
stimulated submaximally and at a time when no ephaptic response was
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elicited.

It is concluded from the present results that the synchronous

firing is ephaptically indue ed, depolarization at the nerve terminal lowers
/

the threshold to stimulation causing more terminals to be stimulated
ephaptically and increasing the amplitude of the ephaptic response.
Moreover, the reduced threshold to stimulation of the nerve terminal
causes the nerve to be stimulated more than once causing the synchronous
firing.

As the muscle becomes paralyzed the action currents of the

muscle are no longer sufficient to excite the nerve, and the asynchronous
firing, which originated in the nerve terminal, remains.

The asynchronous

firing also disappeared when the muscle was totally paralyzed and did not
reappear as the muscle recovered spontaneously from the blockade.
B.

The effect of facilitatory and depolarizing drugs in the absence
of nerve stimulation

Neostigmine and edrophonium produced firing in the nerve following a
latent period.

The response of the nerve corresponded to fasciculations

in the muscle which have been previously reported by Randall (1950) and
Blaber and Bowman (1959).

It is possible that these two drugs may

produce depolarization at the nerve terminal since at higher dose levels
they are known to depolarize the motor end-plate and to directly stimulate
the muscle (Wescoe and Riker,
Blaber and Christ, 1967).

1951; Nastuk and Alexander, 1954:

r
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Ambenonium will also produce antidromic firing in the motor nerve
in the absence of nerve stimulation, although the latent perioj is 15 sec.
as compared to 2-3 sec. for neostigmine and edrophonium, and the firing
lasts for more than one hour as compared to 30 minutes for neostigmine
and edrophonium.

The firing produced by ambenonium is difficult to

explain since the drug has never been reported to have depolarizing
properties and is a comp·.3titive blocking drug at the neuromuscular
junction at higher dose levels {Blaber,

1960).

The possibility exists

that since this drug is a powerful anticholinesterase and, in contrast to the
other facilitatory drugs used, could inhibit cholinesterase at the dose
levels used {Blaber, 1963).

Therefore, acetylcholine preserved at the

junction could be producing these effects.

This may account for the

longer latency before the antidromic firing commences.

A similar

explanation was used by Blaber and Bowman {1963 a) to account for the
prolonged antidromic firing, following orthodromic stimulation, in the
presence of ambenonium.
Succinylcholine and decamethonium also produced antidromic
firing in the nerve, in the absence of stimulation, following a latent
period.

The effects were produced by low doses {0. 5 p.g c. a.) and the

response in the nerve preceded those in the muscle.

At higher dose

levels of the depolarizing drugs, there was no activity in the nerve but
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an

imm~diate

response was produced in the muscle, this being,
/

presumably, the response to depolarization of the end-plate.

It can be concluded,therefore, that the nerve terminal is more
sensitive to depolarization than the end-plate and that the muscle
fasciculations produced by low doses of the depolarizing drugs are a
result of depolarization of the nerve terminal.

At higher dose levels the

nerve is no longer stimulated, possibly the intense depolarization
producing a blocking action_ resembling cathodal block.

At this dose

level the end-plate is depolarized producing an immediate muscle
response.

It must also be concluded that at dose levels which block transmission not only is the neuromuscular junction blocked postsynaptically
but also presynaptically,

this presynaptic block being also responsible

for the disappearance of the antidromic firing following orthodromic
stimulation when the muscle is totally paralyzed.
Acetylcholine produced very little response when administered
close-arterially in doses of 0. 01-50 p.g, confirming the results of
Riker (1966) who found that doses of 100 p.g/kg. c. a., i.e. , 300 p.g in an
average 3 kg. cat were required to produce antidromic firing.

Masland

and Wigton (1940) observed antidromic firing in response to 100 p.g
acetylcholine given distant arterially.

This was confirmed in the p :-.:esent
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experiments where it was found that a dose of 50 ,ug
would produce firing if given distant .arterially.

/

Sine e it was difficult to

evaluate the results of these experiments the site of action being unknown,
they were not elaborated upon, but an equivalent dose of choline did not
produce a response and, therefore, the firing was due to the acetylcholine .

•
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II.

EFFECT OF DRUG COMBINATIONS
A.

Effect of the combined administration of the facilitatory and
depolarizing drugs following stimulation by a single volley

The combined administration of any two of the facilitatory drugs
augmented the antidromic firing observed following an orthodromic
stimulus.

However, due to the intense response produced by ambenonium

alone the augmentation was not marked.

The combination of either

edrophonium or neostigmine with methoxyambenonium markedly augmented
the antidromic firing both with regard to amplitude and duration of the
drug response even though methoxyambenonium by itself produced no
response.

The combination of a facilitatory drug and a depolarizing drug

augmented the amplitude but shortened the time of drug response of the
depolarizing drug given alone with the exception of methoxyambenonium
which augmented both the amplitude and duration of action.
Combination of a depolarizing drug with either edrophonium, neostigmine or ambenonium augmented the muscle twitch in the facilitat.ory phase
and deepened the block compared to a control response, confirming the
result of Blaber and Karczmar (1967) with neostigmine.

The increased

muscle block was probably responsible for the decreased duration of the
nerve response.

The effect of a combination of methoxyambenonium and a

depolarizer, in the present results, produced antidromic discharges following a greater number of orthodromic stimuli when compared with the
administration of the depolarizing agent alone.

Karc zmar ( 1957) and Blaber

104
and Karczmar (1967} described the

11

reversaP 1 response produced by a

combination of methoxyambenonium and a depolarizing drug.

In this regard

the usual response produced by a depolarizing drug of facilita{ion followed
by blockade was converted to a response consisting of only facilitation,
which was augmented and prolonged over the control response.
B.

The effect of a combination of the facilitatory and depolarizing
drugs in the absence of nerve stimulation

Any two

facil~tatory

drugs produced an augmented and prolonged re-

sponse when compared to either alone.

The same was true for edrophonium,

neostigmine and ambenonium when combined with a depolarizing drug.
However, when methoxyambenonium, which by itself produced no response,
was combined with a depolarizing drug, the response of the depolarizing
drug was blocked.
When methoxyambenonium or neostigmine was administered distant
.arterially previous to a dose of acetylcholine both drugs augmented the
response to acetylcholine, thus showing the possibility of a different site of
action of the acetylcholine.
The fact that methoxyambenonium will augment the antidromic firing
following an orthodromic stimulus in the presence of a depolarizing drug
and yet will block the response in the absence of nerve stimulation leads
to the conclusion that the antidromic firing following a stimulus and the
antidromic firing in the absence of stimulation originate at different sites.
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c.

The effect of tubocurarine on the response of the facilitatory and
/

depolarizing drugs in the motor nerve

Tubocurarine administered i. v. before the facilitatory or depolarizing
drugs abolished the antidromic firing produced either following an orthodromic stimulus or in the absence of stimulation.

The dose of tubocurarine

necessary to do this depressed the twitch approximately 20o/o at the peak
blockade.

However, the antidromic response was abolished for approxi-

mately one hour, whereas the slight tubocurarine blockade lasted only five
minutes.
Tubocurarine will therefore abolish antidromic firing at both sites on
the nerve terminal at a time when the muscle is not blocked.
D.

The effect of facilitatory and depolarizing drugs when acetylcholine is depleted from the nerve terminal

Hemicholinium (SJ.ueler,

1955; Mcintosh,

1961) and triethylcholine

(Bowman and Rand, 1961) were used to deplete the motor nerve terminal
of acetylcholine.

Neither HC -3 or TEC changed the response of the

facilitatory or depolarizing drugs when the nerve was stimulated once every
ten seconds.

With these conditions there is no depletion of transmitter.

When the nerve was stimulated at a rate of one per second inconsistent
results were obtained.

Control responses were obtained to both the

facilitatory and depolarizing drugs immediately following the administration
of HC -3 or TEC.

However, when the muscle was blocked by the HC -3 or
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TEC in some cases the facilitatory drugs produced a control res:Ponse, in
/

some cases with a diminished response and in some cases with no response.
The depolarizing drugs sometimes produced a control response, sometimes the synchronous firing was blocked leaving the asynchronous firing
and sometimes the response was completely blocked.

When tetanic

stimulation of the nerve was used the response to the facilitatory and
depolarizing drugs were not diminished immediately following the
administration of HC-3 or TEC; however, at maximal block the response
to both the facilitatory and depolarizing drugs was abolished.
It was observed that at the time of maximal block by HC -3 or TEC
the amplitude of the spikes as recorded from the ventral root was
increased.

It is difficult to explain this result as hyperpolarization since

the response was recorded from the ventral root presumably. devoid of its
blood supply.

Choline, the specific antagonist of HC-3 and TEC reversed

the effect on the spikes and the response to the facilitatory and depolarizing
drugs returned.
No conclusion can be drawn for these results concerning the
possibility of acetylcholine mediating in the response of the facilitatory
drugs since the response to the depolarizing drugs was also blocked, the
mechanism being unknown.
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III.

THE EFFECT OF DEPOLARIZING DRUGS ON MINIATURE END/

PLATE POTENTIAL FREQUENCY
Them. e. p. p. frequency is a measure of the membrane potential of the
motor nerve terminal.

The cat tenuissimus has been used which responds

in the same way to drugs as the anterior tibialis muscle (Maclagan, 1962).
The m. e. p. p. frequency was not changed by concentrations of
succinylcholine or decamethonium ranging from l0- 12 M to 10- 6 M.
Decamethonium depolarized_ the end-plate at 5 X 10- 6 M and succinylcholine
at 10- 7 M.
It may be concluded from these experiments that neither decametho-

nium or succinylcholine depolarize the motor nerve terminal and that the
antidromic firing produced in the absence of nerve stimulation must
originate from a site on the motor nerve more central than the nerve
terminal.
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IV •

GE NE RAL

D I SC U SSI 0 N
/

Werner (1961) comparing ephaptic responses with drug induced antidromic firing concluded that the loop time for stimulation of a ventral
rootlet to recording the response in a ventral root filament was shorter
than expected if conduction along the entire loop was to take place.

He

concluded that the stimulus from the muscle action currents stimulated the
intramuscular axons rather than the unmylinated terminals.

He also

concluded that a focal stimulus in the muscle also stimulated the intramuse ular axon.

Hubbard, S::hmidt, and Yokota ( 1965) stimulated the

motor nerve terminal through a microelectrode and concluded that their
point of stimulus was not the unmyelinated terminal and reasoned that
their technique would not permit stimulation of a distant site.

They

decided, therefore, that the first node was the point of stimulation.
For the purpose of this discussion we shall assume that the point
of stimulation is the first node and that the ephaptic response originates at
this point.
It follows that the decrease in threshold to ephaptic stimulation

occurs at the first node and, therefore, this is the point at which the
depolarizing drugs act, both to augment the ephaptic response and to
produce antidromic firing in the absence of nerve stimulation.

The present

results have also shown that the depolarizing drugs do not increase

r

1 09

m. e. p. p. 's frequency and, therefore, do not depolarize the unmyelinated
terminal.

Methoxyambenonium blocks the antidromic firing/produced by

the depolarizing drugs in the absence of stimulation at the first node.

This

is probably due to the curare -like action of methoxyambenonium (Blaber,
1960) since tubocurarine also blocked this action.

The facilitatory drugs

must also produce antidromic firing in the absence of nerve stimulation
at the first node since they do not depolarize the unmyelinated terminal
(Blaber and Christ, 196 7).

It has been concluded that the antidromic firing produced by the
facilitatory drugs following an orthodromic stimulus originates in the
unmyelinated terminal (Werner, 1960 a & b,
1963; Blaber and Bowman, 1963 a & b).

1961; Hubbard and S:hmidt,

It is reasoned that the drugs

augment and prolong the negative after potential following an orthodromic
stimulus which produces a repetitive stimulation of the first node.

The

depolarizing drugs either produce a similar action on the unmyelinated
terminal in addition to the depolarization at the first node or depolarization
of the first node reduces the threshold sufficiently for an unchanged
negative after potential to stimulate it.

The latter explanation is unlikely

since methoxyambenonium would prevent depolarization of the first node
while augmenting the antidromic firing following an orthodromic stimulus.
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If the first node is a point of stimulation at the neuromuscular junction

for the ephaptic response, the evidence in this thesis supports the
/

following proposals:

1.

Facilitatory drugs do not appear to act by depolarization of the
terminals or the first node.

2.

The response of the facilitatory drugs at the motor nerve terminal does
not appear to be mediated by acetylcholine since acetylcholine is
ineffective in producing these responses.

3.

Depolarizing drugs appear to lower the threshold to stimulation at
the first node and may also augment the negative after potential in
the unmyelinated terminal.
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